8,565,317 results on '"Male"'
Search Results
2. Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.
- Author
-
Akaike, Tomoko, Thakuria, Manisha, Silk, Ann, Hippe, Daniel, Park, Song, So, Naomi, Maloney, Nolan, Gunnell, Lindsay, Eschholz, Alec, Kim, Emily, Sinha, Sumi, Hall, Evan, Bhatia, Shailender, Reddy, Sunil, Rodriguez, Angel, Aleshin, Alexey, Choi, Jacob, Tsai, Kenneth, Yom, Sue, Yu, Siegrid, Choi, Jaehyuk, Chandra, Sunandana, Nghiem, Paul, and Zaba, Lisa
- Subjects
Humans ,Carcinoma ,Merkel Cell ,Male ,Female ,Circulating Tumor DNA ,Aged ,Neoplasm Recurrence ,Local ,Skin Neoplasms ,Prospective Studies ,Middle Aged ,Disease Progression ,Prognosis ,Aged ,80 and over ,Neoplasm ,Residual ,Biomarkers ,Tumor ,Adult - Abstract
PURPOSE: Merkel cell carcinoma (MCC) is an aggressive skin cancer with a 40% recurrence rate, lacking effective prognostic biomarkers and surveillance methods. This prospective, multicenter, observational study aimed to evaluate circulating tumor DNA (ctDNA) as a biomarker for detecting MCC recurrence. METHODS: Plasma samples, clinical data, and imaging results were collected from 319 patients. A tumor-informed ctDNA assay was used for analysis. Patients were divided into discovery (167 patients) and validation (152 patients) cohorts. Diagnostic performance, including sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), was assessed. RESULTS: ctDNA showed high sensitivity, 95% (discovery; 95% CI, 87 to 99) and 94% (validation; 95% CI, 85 to 98), for detecting disease at enrollment, with corresponding specificities of 90% (95% CI, 82 to 95) and 86% (95% CI, 77 to 93). A positive ctDNA during surveillance indicated increased recurrence risk, with hazard ratios (HRs) of 6.8 (discovery; 95% CI, 2.9 to 16) and 20 (validation; 95% CI, 8.3 to 50). The PPV for clinical recurrence at 1 year after a positive ctDNA test was 69% (discovery; 95% CI, 32 to 91) and 94% (validation; 95% CI, 71 to 100), respectively. The NPV at 135 days after a negative ctDNA test was 94% (discovery; 95% CI, 90 to 97) and 93% (validation; 95% CI, 89 to 97), respectively. Patients positive for ctDNA within 4 months after treatment had higher rates of recurrence, with 1-year rates of 74% versus 21% (adjusted HR, 7.4 [95% CI, 2.7 to 20]). CONCLUSION: ctDNA testing exhibited high prognostic accuracy in detecting MCC recurrence, suggesting its potential to reduce frequent surveillance imaging. ctDNA also identifies high-risk patients who need more frequent imaging and may be best suited for adjuvant therapy trials.
- Published
- 2024
3. Long-Term Dementia Risk in Parkinson Disease.
- Author
-
Gallagher, Julia, Gochanour, Caroline, Caspell-Garcia, Chelsea, Dobkin, Roseanne, Aarsland, Dag, Alcalay, Roy, Barrett, Matthew, Chahine, Lana, Chen-Plotkin, Alice, Coffey, Christopher, Dahodwala, Nabila, Eberling, Jamie, Espay, Alberto, Leverenz, James, Litvan, Irene, Mamikonyan, Eugenia, Morley, James, Richard, Irene, Rosenthal, Liana, Siderowf, Andrew, Simuni, Tatyana, York, Michele, Willis, Allison, Xie, Sharon, and Weintraub, Daniel
- Subjects
Humans ,Parkinson Disease ,Dementia ,Male ,Female ,Aged ,Middle Aged ,Prospective Studies ,Cohort Studies ,Risk Factors ,Disease Progression ,Neuropsychological Tests ,Mental Status and Dementia Tests - Abstract
BACKGROUND AND OBJECTIVES: It is widely cited that dementia occurs in up to 80% of patients with Parkinson disease (PD), but studies reporting such high rates were published over two decades ago, had relatively small samples, and had other limitations. We aimed to determine long-term dementia risk in PD using data from two large, ongoing, prospective, observational studies. METHODS: Participants from the Parkinsons Progression Markers Initiative (PPMI), a multisite international study, and a long-standing PD research cohort at the University of Pennsylvania (Penn), a single site study at a tertiary movement disorders center, were recruited. PPMI enrolled de novo, untreated PD participants and Penn a convenience cohort from a large clinical center. For PPMI, a cognitive battery is administered annually, and a site investigator makes a cognitive diagnosis. At Penn, a comprehensive cognitive battery is administered either annually or biennially, and a cognitive diagnosis is made by expert consensus. Interval-censored survival curves were fit for time from PD diagnosis to stable dementia diagnosis for each cohort, using cognitive diagnosis of dementia as the primary end point and Montreal Cognitive Assessment (MoCA) score
- Published
- 2024
4. Folate Metabolism and Risk of Childhood Acute Lymphoblastic Leukemia: A Genetic Pathway Analysis from the Childhood Cancer and Leukemia International Consortium.
- Author
-
Metayer, Catherine, Spector, Logan, Scheurer, Michael, Jeon, Soyoung, Scott, Rodney, Takagi, Masatoshi, Clavel, Jacqueline, Manabe, Atsushi, Ma, Xiaomei, Hailu, Elleni, Lupo, Philip, Urayama, Kevin, Bonaventure, Audrey, Kato, Motohiro, Meirhaeghe, Aline, Chiang, Charleston, Morimoto, Libby, and Wiemels, Joseph
- Subjects
Humans ,Precursor Cell Lymphoblastic Leukemia-Lymphoma ,Folic Acid ,Polymorphism ,Single Nucleotide ,Child ,Case-Control Studies ,Female ,Male ,Genome-Wide Association Study ,Risk Factors ,Genetic Predisposition to Disease ,Child ,Preschool - Abstract
BACKGROUND: Prenatal folate supplementation has been consistently associated with a reduced risk of childhood acute lymphoblastic leukemia (ALL). Previous germline genetic studies examining the one carbon (folate) metabolism pathway were limited in sample size, scope, and population diversity and led to inconclusive results. METHODS: We evaluated whether ∼2,900 single-nucleotide polymorphisms (SNP) within 46 candidate genes involved in the folate metabolism pathway influence the risk of childhood ALL, using genome-wide data from nine case-control studies in the Childhood Cancer and Leukemia International Consortium (n = 9,058 cases including 4,510 children of European ancestry, 3,018 Latinx, and 1,406 Asians, and 92,364 controls). Each study followed a standardized protocol for quality control and imputation of genome-wide data and summary statistics were meta-analyzed for all children combined and by major ancestry group using METAL software. RESULTS: None of the selected SNPs reached statistical significance, overall and for major ancestry groups (using adjusted Bonferroni P-value of 5 × 10-6 and less-stringent P-value of 3.5 × 10-5 accounting for the number of independent SNPs). None of the 10 top (nonsignificant) SNPs and corresponding genes overlapped across ancestry groups. CONCLUSIONS: This large meta-analysis of original data does not reveal associations between many common genetic variants in the folate metabolism pathway and childhood ALL in various ancestry groups. IMPACT: Genetic variants in the folate pathway alone do not appear to substantially influence childhood acute lymphoblastic leukemia risk. Other mechanisms such as gene-folate interaction, DNA methylation, or maternal genetic effects may explain the observed associations with self-reported prenatal folate intake.
- Published
- 2024
5. SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency.
- Author
-
Chan, Yi-Hao, Lundberg, Vanja, Le Pen, Jérémie, Yuan, Jiayi, Lee, Danyel, Pinci, Francesca, Volpi, Stefano, Nakajima, Koji, Bondet, Vincent, Åkesson, Sanna, Khobrekar, Noopur, Bodansky, Aaron, Du, Likun, Melander, Tina, Mariaggi, Alice-Andrée, Seeleuthner, Yoann, Saleh, Tariq, Chakravarty, Debanjana, Marits, Per, Dobbs, Kerry, Vonlanthen, Sofie, Hennings, Viktoria, Thörn, Karolina, Rinchai, Darawan, Bizien, Lucy, Chaldebas, Matthieu, Sobh, Ali, Özçelik, Tayfun, Keles, Sevgi, AlKhater, Suzan, Prando, Carolina, Meyts, Isabelle, Wilson, Michael, Rosain, Jérémie, Jouanguy, Emmanuelle, Aubart, Mélodie, Abel, Laurent, Mogensen, Trine, Pan-Hammarström, Qiang, Gao, Daxing, Duffy, Darragh, Cobat, Aurélie, Berg, Stefan, Notarangelo, Luigi, Harschnitz, Oliver, Rice, Charles, Studer, Lorenz, Casanova, Jean-Laurent, Ekwall, Olov, and Zhang, Shen-Ying
- Subjects
Humans ,Male ,SARS-CoV-2 ,COVID-19 ,Brain Stem ,Adolescent ,Neurons ,Encephalitis ,Viral ,Fibroblasts ,Rhombencephalon - Abstract
Inherited deficiency of the RNA lariat-debranching enzyme 1 (DBR1) is a rare etiology of brainstem viral encephalitis. The cellular basis of disease and the range of viral predisposition are unclear. We report inherited DBR1 deficiency in a 14-year-old boy who suffered from isolated SARS-CoV-2 brainstem encephalitis. The patient is homozygous for a previously reported hypomorphic and pathogenic DBR1 variant (I120T). Consistently, DBR1 I120T/I120T fibroblasts from affected individuals from this and another unrelated kindred have similarly low levels of DBR1 protein and high levels of RNA lariats. DBR1 I120T/I120T human pluripotent stem cell (hPSC)-derived hindbrain neurons are highly susceptible to SARS-CoV-2 infection. Exogenous WT DBR1 expression in DBR1 I120T/I120T fibroblasts and hindbrain neurons rescued the RNA lariat accumulation phenotype. Moreover, expression of exogenous RNA lariats, mimicking DBR1 deficiency, increased the susceptibility of WT hindbrain neurons to SARS-CoV-2 infection. Inborn errors of DBR1 impair hindbrain neuron-intrinsic antiviral immunity, predisposing to viral infections of the brainstem, including that by SARS-CoV-2.
- Published
- 2024
6. New persistent opioid use following robotic-assisted, laparoscopic and open surgery inguinal hernia repair.
- Author
-
MacQueen, Ian, Milky, Gediwon, Shih, I-Fan, Zheng, Feibi, and Chen, David
- Subjects
Inguinal hernia repair ,Minimally invasive surgery ,Persistent opioid use ,Robotic surgery ,Humans ,Robotic Surgical Procedures ,Male ,Retrospective Studies ,Female ,Middle Aged ,Analgesics ,Opioid ,Hernia ,Inguinal ,Laparoscopy ,Pain ,Postoperative ,Herniorrhaphy ,Adult ,Aged ,Opioid-Related Disorders - Abstract
INTRODUCTION: Post-operative prescription opioid use is a known risk factor for persistent opioid use. Despite the increased utilization of robotic-assisted surgery (RAS) for inguinal hernia repair (IHR), little is known whether this minimally invasive approach results in less opioid consumption. In this study, we compare long-term opioid use between RAS versus laparoscopic (Lap) versus open surgery for IHR. METHODS: A retrospective cohort study of opioid-naïve patients who underwent outpatient primary IHR was conducted using the Merative™ MarketScan® (Previously IBM MarketScan®) Databases between 2016 and 2020. Patients not continuously enrolled 180 days before/after surgery, who had malignancy, pre-existing chronic pain, opioid dependency, or invalid prescription fill information were excluded. Among patients exposed to opioids peri-operatively, we assessed long-term opioid use as any opioid prescription fill within 90 to 180 days post-surgery. Secondary outcomes were controlled substance schedule II/III opioid fill, and high-dose opioid fill defined as > 50 morphine milligram equivalent per day. An Inverse-probability of treatment weighted logistic regression was used to compare outcomes between groups with p-value of
- Published
- 2024
7. Cannabis consumers’ preferences for legal and illegal cannabis: evidence from a discrete choice experiment
- Author
-
Xing, Jin and Shi, Yuyan
- Subjects
Epidemiology ,Health Services and Systems ,Public Health ,Health Sciences ,Cannabinoid Research ,Drug Abuse (NIDA only) ,Substance Misuse ,Clinical Research ,Humans ,Male ,Adult ,Female ,Consumer Behavior ,Cannabis ,United States ,Choice Behavior ,Young Adult ,Commerce ,Middle Aged ,Adolescent ,Legislation ,Drug ,Cannabis dispensary ,Cannabis legalization ,Discrete choice experiment ,Illegal markets ,Mixed logit ,Public Health and Health Services ,Health services and systems ,Public health - Abstract
BackgroundIn U.S. states that legalized and commercialized recreational cannabis, cannabis sales in illegal markets are still sizable or even larger than those in legal markets. This study aimed to assess cannabis consumers' preferences for purchasing cannabis from legal and illegal markets and estimate the trade-offs under various policy scenarios.Methods963 adults were recruited, who used cannabis in the past year and lived in a state with recreational cannabis legalization. In a discrete choice experiment, participants chose purchasing cannabis from a legal dispensary or an illegal dealer with varying levels in product attributes including quality, safety, accessibility, potency, and price. Mixed logit models were used to analyze preferences.ResultsThe likelihood of choosing legal cannabis increased with a higher quality, the presence of lab test, a shorter distance to seller, a higher tetrahydrocannabinol level, and a lower price. The likelihood of choosing illegal cannabis increased with a higher quality, a shorter distance to seller, and a lower price. Among product attributes, quality and accessibility were perceived to be the most important for legal cannabis and price was perceived to be the most important for illegal cannabis. Policy simulations predicted that improving quality, ensuring safety, allowing delivery services, increasing dispensary density, and lowering prices/taxes of legal cannabis may reduce illegal cannabis market share.ConclusionsIn the U.S., cannabis consumers' preferences for illegal cannabis were associated with both legal and illegal cannabis product attributes. Policies regulating legal cannabis markets should consider potential spillover effects to illegal markets.
- Published
- 2024
8. Effects of Psychedelics in Older Adults: A Prospective Cohort Study.
- Author
-
Kettner, Hannes, Roseman, Leor, Gazzaley, Adam, Carhart-Harris, Robin, and Pasquini, Lorenzo
- Subjects
Aging ,cohort study ,mental health ,naturalistic research ,psychedelics ,well-being ,Humans ,Hallucinogens ,Male ,Female ,Prospective Studies ,Aged ,Middle Aged ,Adult ,Young Adult - Abstract
OBJECTIVE: Affective symptoms such as anxiety, low mood, and loneliness are prevalent and highly debilitating symptoms among older adults (OA). Serotonergic psychedelics are currently investigated as novel interventions for affective disorders, yet little is known regarding their effects in OA. We investigated the mental health effects and psychological mechanisms of guided psychedelic group experiences in OA and a matched sample of younger adults (YA). METHODS: Using a prospective observational cohort design, we identified 62 OA (age ≥60 years) and 62 matched YA who completed surveys two weeks before, a day, two weeks, four weeks, and six months after a psychedelic group session. Mixed linear regression analyses were used to investigate longitudinal well-being changes, as well as baseline, acute, and post-acute predictors of change. RESULTS: OA showed post-psychedelic well-being improvements similar to matched YA. Among baseline predictors, presence of a lifetime psychiatric diagnosis was associated with greater well-being increases in OA (B = 6.72, p = .016 at the four-week key-endpoint). Compared to YA, acute subjective psychedelic effects were less intense in OA and did not significantly predict prospective well-being changes. However, relational experiences before and after psychedelic sessions emerged as predictors in OA (r(36) = .37,p = 0.025). CONCLUSIONS: Guided psychedelic group sessions enhance well-being in OA in line with prior naturalistic and controlled studies in YA. Interestingly, acute psychedelic effects in OA are attenuated and less predictive of well-being improvements, with relational experiences related to the group setting playing a more prominent role. Our present findings call for further research on the effects of psychedelics in OA.
- Published
- 2024
9. PTER is a N-acetyltaurine hydrolase that regulates feeding and obesity.
- Author
-
Wei, Wei, Lyu, Xuchao, Markhard, Andrew, Fu, Sipei, Mardjuki, Rachel, Cavanagh, Peter, Zeng, Xianfeng, Rajniak, Jakub, Lu, Nannan, Xiao, Shuke, Zhao, Meng, Moya-Garzon, Maria, Truong, Steven, Chou, Jonathan, Wat, Lianna, Chidambaranathan-Reghupaty, Saranya, Coassolo, Laetitia, Xu, Duo, Shen, Fangfang, Huang, Wentao, Ramirez, Cuauhtemoc, Jang, Cholsoon, Li, Lingyin, Svensson, Katrin, Fischbach, Michael, and Long, Jonathan
- Subjects
Animals ,Female ,Humans ,Male ,Mice ,Eating ,Glucose ,Homeostasis ,Hydrolases ,Hydrolysis ,Kidney ,Liver ,Mice ,Inbred C57BL ,Mice ,Knockout ,Obesity ,Taurine ,Carrier Proteins ,Acetic Acid ,Exercise ,Body Mass Index ,Weight Loss ,Secondary Metabolism ,Energy Metabolism ,Body Weight ,Brain Stem - Abstract
Taurine is a conditionally essential micronutrient and one of the most abundant amino acids in humans1-3. In endogenous taurine metabolism, dedicated enzymes are involved in the biosynthesis of taurine from cysteine and in the downstream metabolism of secondary taurine metabolites4,5. One taurine metabolite is N-acetyltaurine6. Levels of N-acetyltaurine are dynamically regulated by stimuli that alter taurine or acetate flux, including endurance exercise7, dietary taurine supplementation8 and alcohol consumption6,9. So far, the identities of the enzymes involved in N-acetyltaurine metabolism, and the potential functions of N-acetyltaurine itself, have remained unknown. Here we show that the body mass index associated orphan enzyme phosphotriesterase-related (PTER)10 is a physiological N-acetyltaurine hydrolase. In vitro, PTER catalyses the hydrolysis of N-acetyltaurine to taurine and acetate. In mice, PTER is expressed in the kidney, liver and brainstem. Genetic ablation of Pter in mice results in complete loss of tissue N-acetyltaurine hydrolysis activity and a systemic increase in N-acetyltaurine levels. After stimuli that increase taurine levels, Pter knockout mice exhibit reduced food intake, resistance to diet-induced obesity and improved glucose homeostasis. Administration of N-acetyltaurine to obese wild-type mice also reduces food intake and body weight in a GFRAL-dependent manner. These data place PTER into a central enzymatic node of secondary taurine metabolism and uncover a role for PTER and N-acetyltaurine in body weight control and energy balance.
- Published
- 2024
10. Developmental Cascades From Maternal Preconception Stress to Child Behavior Problems: Testing Multilevel Preconception, Prenatal, and Postnatal Influences
- Author
-
Rinne, Gabrielle R, Barclay, Margot E, Somers, Jennifer A, Mahrer, Nicole E, Shalowitz, Madeleine U, Ramey, Sharon Landesman, Schetter, Christine Dunkel, and Lee, Steve S
- Subjects
Social and Personality Psychology ,Psychology ,Clinical Research ,Mental Health ,Pediatric ,Conditions Affecting the Embryonic and Fetal Periods ,Behavioral and Social Science ,Basic Behavioral and Social Science ,Social Determinants of Health ,Women's Health ,2.3 Psychological ,social and economic factors ,Mental health ,Good Health and Well Being ,Humans ,Female ,Child ,Preschool ,Stress ,Psychological ,Pregnancy ,Male ,Temperament ,Prenatal Exposure Delayed Effects ,Parenting ,Adult ,Problem Behavior ,Child Behavior Disorders ,Hydrocortisone ,Child Behavior ,Specialist Studies in Education ,Cognitive Sciences ,Developmental & Child Psychology ,Specialist studies in education ,Applied and developmental psychology ,Cognitive and computational psychology - Abstract
Although maternal stress during pregnancy and even before conception shapes offspring risk for mental health problems, relatively little is known about the mechanisms through which these associations operate. In theory, preconception and prenatal stress may affect offspring mental health by influencing child responses to postnatal caregiving. To address this knowledge gap, this study had two aims. First, we examined associations between preconception and prenatal stress with child temperament profiles at age four using multilevel assessment of maternal perceived stress and stress physiology. Second, we tested child temperament profiles as moderators of associations between observed parenting behaviors during a parent-child free-play interaction when children were 4 years old and child behavior problems 1 year later. Latent profile analyses yielded four distinct child temperament profiles: inhibited, exuberant, regulated low reactive, and regulated high reactive. Consistent with hypotheses, preconception, and prenatal stress each independently predicted the likelihood of children having temperament profiles characterized by higher negative emotionality and lower regulation. Specifically, preconception perceived stress and prenatal cortisol predicted likelihood of children having an exuberant temperament, whereas prenatal perceived stress predicted likelihood of children having an inhibited temperament. Contrary to hypotheses, temperament profiles did not moderate predictions of child behavior problems from observed parenting behaviors; however, responsive parenting behaviors inversely predicted child behavior problems independently of child temperament. These findings add to growing evidence regarding effects of preconception factors on child outcomes and underscore a central role for responsive parenting behaviors in predicting more favorable child mental health independent of child temperament. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
- Published
- 2024
11. Effect of Jardiance on glucose uptake into astrocytomas
- Author
-
Ghezzi, Chiara, Ellingson, Benjamin M, Lai, Albert, Liu, Jie, Barrio, Jorge R, and Wright, Ernest M
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Brain Disorders ,Diabetes ,Clinical Research ,Brain Cancer ,Cancer ,Rare Diseases ,Biomedical Imaging ,Clinical Trials and Supportive Activities ,6.1 Pharmaceuticals ,5.1 Pharmaceuticals ,Humans ,Astrocytoma ,Brain Neoplasms ,Glucose ,Sodium-Glucose Transporter 2 Inhibitors ,Male ,Sodium-Glucose Transporter 2 ,Positron-Emission Tomography ,Glucosides ,Female ,Middle Aged ,Fluorodeoxyglucose F18 ,Aged ,Glioblastoma ,Me4FDG ,PET ,SGLT2 ,SGLT2i ,Neurosciences ,Oncology & Carcinogenesis ,Oncology and carcinogenesis - Abstract
PurposeSGLT2, the sodium glucose cotransporter two, is expressed in human pancreatic, prostate and brain tumors, and in a mouse cancer model SGLT2 inhibitors reduce tumor glucose uptake and growth. In this study we have measured the effect of a specific SGLT2 inhibitor, Jardiance® (Empagliflozin), on glucose uptake into astrocytomas in patients.MethodsWe have used a specific SGLT glucose tracer, α-methyl-4-[18F]fluoro-4-deoxy-α-D-glucopyranoside (Me4FDG), and Positron Emission Tomography (PET) to measure glucose uptake. Four of five patients enrolled had WHO grade IV glioblastomas, and one had a low grade WHO Grade II astrocytoma. Two dynamic brain PET scans were conducted on each patient, one before and one after treatment with a single oral dose of Jardiance, a specific SGLT2 inhibitor. As a control, we also determined the effect of oral Jardiance on renal SGLT2 activity.ResultsIn all five patients an oral dose (25 or 100 mg) of Jardiance reduced Me4FDG tumor accumulation, highly significant inhibition in four, and inhibited SGLT2 activity in the kidney.ConclusionsThese initial experiments show that SGLT2 is a functional glucose transporter in astocytomas, and Jardiance inhibited glucose uptake, a drug approved by the FDA to treat type 2 diabetes mellitus (T2DM), heart failure, and renal failure. We suggest that clinical trials be initiated to determine whether Jardiance reduces astrocytoma growth in patients.
- Published
- 2024
12. Reverse total shoulder arthroplasty with proximal bone loss: a biomechanical comparison of partially vs. fully cemented humeral stems
- Author
-
Maturana, Carlos, Peterson, Brandon, Shi, Brendan, Mooney, Bailey, Clites, Tyler, and Kremen, Thomas J
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Osteoporosis ,Bioengineering ,Assistive Technology ,Humans ,Arthroplasty ,Replacement ,Shoulder ,Biomechanical Phenomena ,Humerus ,Cadaver ,Aged ,Prosthesis Design ,Shoulder Prosthesis ,Female ,Bone Cements ,Male ,Cementation ,Shoulder Joint ,Aged ,80 and over ,Polymethyl Methacrylate ,Reverse total shoulder arthroplasty ,humeral stems ,implant subsidence ,shoulder biomechanics ,proximal humerus fracture ,bone cement ,Orthopedics ,Clinical sciences - Abstract
BackgroundThe appropriate amount of cementation at the time of reverse total shoulder arthroplasty with significant proximal bone loss or resection is unknown. Extensive cementation of a humeral prosthesis makes eventual revision arthroplasty more challenging, increasing the risk of periprosthetic fracture. We analyzed the degree of subsidence and torque tolerance of humeral components undergoing standard cementation technique vs. our reduced polymethyl methacrylate (PMMA) protocol. Reduced cementation may provide sufficient biomechanical stability to resist physiologically relevant loads, while still permitting a clinically attainable torque for debonding the prosthesis.MethodsA total of 12 cadaveric humeri (6 matched pairs) underwent resection of 5 cm of bone distal to the greater tuberosity. Each pair of humeri underwent standard humeral arthroplasty preparation followed by either cementation using a 1.5-cm PMMA sphere at a location 3 cm inferior to the porous coating or standard full stem cementation. A 6-degree-of-freedom robot was used to perform all testing. Each humeral sample underwent 200 cycles of abduction, adduction, and forward elevation while being subjected to a physiologic compression force. Next, the samples were fixed in place and subjected to an increasing torque until implant-cement separation or failure occurred. Paired t tests were used to compare mean implant subsidence vs. a predetermined 5-mm threshold, as well as removal torque in matched samples.ResultsFully and partially cemented implants subsided 0.49 mm (95% CI 0.23-0.76 mm) and 1.85 mm (95% CI 0.41-3.29 mm), respectively, which were significantly less than the predetermined 5-mm threshold (P
- Published
- 2024
13. Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
- Author
-
Miller, Phoebe, Romero-Hernandez, Fernanda, Calthorpe, Lucia, Wang, Jaeyun, Kim, Sunhee, Corvera, Carlos, Hirose, Kenzo, Kirkwood, Kimberly, Hirose, Ryutaro, Maker, Ajay, Alseidi, Adnan, Adam, Mohamed, Kim, Grace, Tempero, Margaret, Ko, Andrew, and Nakakura, Eric
- Subjects
Humans ,Pancreatic Neoplasms ,Neoadjuvant Therapy ,Antineoplastic Combined Chemotherapy Protocols ,Male ,Female ,Retrospective Studies ,Leucovorin ,Irinotecan ,Fluorouracil ,Survival Rate ,Middle Aged ,Oxaliplatin ,Aged ,Follow-Up Studies ,Prognosis ,Pancreatectomy ,Carcinoma ,Pancreatic Ductal ,Adult - Abstract
BACKGROUND: In 2023 alone, its estimated that over 64,000 patients will be diagnosed with PDAC and more than 50,000 patients will die of the disease. Current guidelines recommend neoadjuvant therapy for patients with borderline resectable and locally advanced PDAC, and data is emerging on its role in resectable disease. Neoadjuvant chemotherapy may increase the number of patients able to receive complete chemotherapy regimens, increase the rate of microscopically tumor-free resection (R0) margin, and aide in identifying unfavorable tumor biology. To date, this is the largest study to examine surgical outcomes after long-duration neoadjuvant chemotherapy for PDAC. METHODS: Retrospective analysis of single-institution data. RESULTS: The routine use of long-duration therapy in our study (median cycles: FOLFIRINOX = 10; gemcitabine-based = 7) is unique. The majority (85%) of patients received FOLFIRINOX without radiation therapy; the R0 resection rate was 76%. Median OS was 41 months and did not differ significantly among patients with resectable, borderline-resectable, or locally advanced disease. CONCLUSIONS: This study demonstrates that in patients who undergo surgical resection after receipt of long-duration neoadjuvant FOLFIRINOX therapy alone, survival outcomes are similar regardless of pretreatment resectability status and that favorable surgical outcomes can be attained.
- Published
- 2024
14. Extraskeletal Ewing Sarcoma of the Gastrointestinal and Hepatobiliary Tract: Deceptive Immunophenotype Commonly Leads to Misdiagnosis.
- Author
-
Shiyanbola, Oyewale, Nigdelioglu, Recep, Dhall, Deepti, González, Iván, Warmke, Laura, Schechter, Shula, Choi, Won-Tak, Hu, Shaomin, Voltaggio, Lysandra, Zhang, Yujie, Liang, Tom, Ko, Huaibin, Charville, Greg, and Longacre, Teri
- Subjects
Humans ,Male ,Diagnostic Errors ,Female ,Sarcoma ,Ewing ,Adult ,Middle Aged ,Gastrointestinal Neoplasms ,Retrospective Studies ,Biliary Tract Neoplasms ,Biomarkers ,Tumor ,Adolescent ,Young Adult ,Child ,Child ,Preschool ,Immunohistochemistry ,Liver Neoplasms ,Immunophenotyping ,RNA-Binding Protein EWS ,Predictive Value of Tests - Abstract
Ewing sarcoma (ES) is an uncommon mesenchymal neoplasm that typically develops as a bone mass, although up to 30% arise in extraskeletal sites. ES of the gastrointestinal (GI) and hepatobiliary tract is rare and may be misdiagnosed as other, more common neoplasms that occur in these sites. However, the correct classification of extraskeletal ES is important for timely clinical management and prognostication. We reviewed our experience of ES in the GI and hepatobiliary tract in order to further highlight the clinicopathologic features of these neoplasms and document the potential for misdiagnosis in this setting. The archives and consultation files of 6 academic institutions were retrospectively queried for cases of ES occurring in the GI and hepatobiliary tract. The histologic slides and ancillary studies were reviewed and clinical data were retrieved for each case through the electronic medical records, when available. Twenty-three patients with ES in the GI and/or hepatobiliary tract were identified from 2000 to 2022. Of these, 11 were women and 12 were men with a median age of 38 years (range, 2 to 64). Tumor locations included the pancreas (n=5), liver (n=2), stomach (n=3), colorectum (n=3), and small intestine (n=5), as well as tumors involving multiple organs, pelvis and retroperitoneum (n=5). Tumor size varied between 2 cm and 18 cm. Twenty were primary and 3 were metastases. Of the 23 cases, only 17% were initially diagnosed as ES. The most common misdiagnoses involved various forms of neuroendocrine neoplasia due to expression of synaptophysin and other neuroendocrine markers (22%). A wide variety of diagnoses including GI stromal tumor was considered due to aberrant CD117 expression (4%). The diagnosis of ES was ultimately confirmed by detection of the EWSR1 rearrangement in 22 cases. The remaining case was diagnosed using traditional immunohistochemistry. Follow-up information was available in 20 cases, with follow-up time varying between 2 and 256 months. Six patients with follow-up died of disease between 6 and 60 months following initial presentation. Our data indicate ES in the GI and hepatobiliary tract is commonly misdiagnosed leading to a delay in therapy. In light of the attendant therapeutic and prognostic implications, ES should be considered in the differential diagnosis of any GI or hepatobiliary tumor with epithelioid and/or small round cell morphology.
- Published
- 2024
15. From targets to solutions: Implementing a trauma quality improvement bundle in Cameroon
- Author
-
Zheng, Dennis J, Yost, Mark T, Mbuh, Lidwine N, Tchekep, Mirene, Boumsong, Jean Baptiste, Tsiagadigui, Jean Gustave, Oke, Rasheedat, Juillard, Catherine, Chichom-Mefire, Alain, and Christie, S Ariane
- Subjects
Health Services and Systems ,Health Sciences ,Clinical Research ,8.1 Organisation and delivery of services ,Humans ,Cameroon ,Quality Improvement ,Wounds and Injuries ,Male ,Female ,Resuscitation ,Trauma Centers ,Checklist ,Adult ,Patient Care Bundles ,Global surgery ,Injury ,Quality improvement ,Sub-Saharan Africa ,Emergency medicine ,Trauma surgery ,Clinical Sciences ,Nursing ,Public Health and Health Services ,Orthopedics ,Biomedical and clinical sciences ,Clinical sciences ,Dentistry ,Health sciences - Abstract
BackgroundGlobal surgery research efforts have been criticized for failure to transition from problem identification to intervention implementation. We developed a context-appropriate trauma quality improvement (TQI) bundle to ameliorate care gaps at a regional referral hospital in Cameroon. We determined associations between bundle implementation and improvement in trauma resuscitation practices.MethodsWe implemented a TQI bundle consisting of a hospital-specific trauma protocol, staff training, a trauma checklist, provision of essential emergency trauma supplies in the resuscitation area, and monthly quality improvement meetings. We compared trends in target process measures (e.g., frequency and timing of vital sign collection and primary survey interventions) in the six-month period pre- and post-bundle implementation using Wilcoxon rank-sum and Fisher's exact tests.ResultsWe compared 246 pre-bundle patients with 203 post-bundle patients. Post-bundle patients experienced a greater proportion of all vital signs collected compared to the pre-intervention cohort (0 % pre-bundle vs. 69 % post-bundle, p < 0.001); specifically, the proportion of respiratory rate (0.8 % pre-bundle vs. 76 % post-bundle, p < 0.001) and temperature (7 % pre-bundle vs. 91 % post-bundle, p < 0.001) vital sign collection significantly increased. The post-bundle cohort had vital signs measured sooner (74 % vital signs measured within 15 min of arrival pre-bundle vs. 90 % post-bundle, p < 0.001) and more frequently per patient (7 % repeated vitals pre-bundle vs 52 % post-bundle, p < 0.001). Key primary survey interventions such as respiratory interventions (1 % pre-bundle vs. 8 % post-bundle, p < 0.001) and cervical collar placement (0 % pre-bundle vs. 7 % post-bundle, p < 0.001) also increased in the post-bundle cohort.ConclusionsThe implementation of a context-appropriate TQI bundle was associated with significant improvements in previously identified trauma care deficits at a single regional hospital. Data-derived interventions targeting frontline capacity at the local level can bridge the gap between identifying care limitations and improvement in resource-limited settings.
- Published
- 2024
16. Nicotine inhalant via E‐cigarette facilitates sensorimotor function recovery by upregulating neuronal BDNF–TrkB signalling in traumatic brain injury
- Author
-
Wang, Dongsheng, Li, Xiaojing, Li, Wenxi, Duong, Tiffany, Wang, Hongxia, Kleschevnikova, Natalia, Patel, Hemal H, Breen, Ellen, Powell, Susan, Wang, Shanshan, and Head, Brian P
- Subjects
Pharmacology and Pharmaceutical Sciences ,Biomedical and Clinical Sciences ,Tobacco ,Traumatic Head and Spine Injury ,Traumatic Brain Injury (TBI) ,Substance Misuse ,Brain Disorders ,Tobacco Smoke and Health ,Physical Injury - Accidents and Adverse Effects ,Neurosciences ,1.1 Normal biological development and functioning ,Neurological ,Mental health ,Good Health and Well Being ,Animals ,Nicotine ,Brain-Derived Neurotrophic Factor ,Male ,Brain Injuries ,Traumatic ,Mice ,Inbred C57BL ,Mice ,Up-Regulation ,Signal Transduction ,Electronic Nicotine Delivery Systems ,Neurons ,Recovery of Function ,Receptor ,trkB ,Administration ,Inhalation ,BDNF ,E-cigarette ,neuroprotection ,nicotine ,sensorimotor function ,traumatic brain injury ,E‐cigarette ,Pharmacology & Pharmacy ,Pharmacology and pharmaceutical sciences - Abstract
Background and purposeTraumatic brain injury (TBI) causes lifelong physical and psychological dysfunction in affected individuals. The current study investigated the effects of chronic nicotine exposure via E-cigarettes (E-cig) (vaping) on TBI-associated behavioural and biochemical changes.Experimental approachAdult C57/BL6J male mice were subjected to controlled cortical impact (CCI) followed by daily exposure to E-cig vapour for 6 weeks. Sensorimotor functions, locomotion, and sociability were subsequently evaluated by nesting, open field, and social approach tests, respectively. Immunoblots were conducted to examine the expression of mature brain-derived neurotrophic factor (mBDNF) and associated downstream proteins (p-Erk, p-Akt). Histological analyses were performed to evaluate neuronal survival and neuroinflammation.Key resultsPost-injury chronic nicotine exposure significantly improved nesting performance in CCI mice. Histological analysis revealed increased survival of cortical neurons in the perilesion cortex with chronic nicotine exposure. Immunoblots revealed that chronic nicotine exposure significantly up-regulated mBDNF, p-Erk and p-Akt expression in the perilesion cortex of CCI mice. Immunofluorescence microscopy indicated that elevated mBDNF and p-Akt expression were mainly localized within cortical neurons. Immunolabelling of Iba1 demonstrated that chronic nicotine exposure attenuated microglia-mediated neuroinflammation.Conclusions and implicationsPost-injury chronic nicotine exposure via vaping facilitates recovery of sensorimotor function by upregulating neuroprotective mBDNF/TrkB/Akt/Erk signalling. These findings suggest potential neuroprotective properties of nicotine despite its highly addictive nature. Thus, understanding the multifaceted effects of chronic nicotine exposure on TBI-associated symptoms is crucial for paving the way for informed and properly managed therapeutic interventions.
- Published
- 2024
17. SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis.
- Author
-
Zhao, Wennan, Wang, Xue, Han, Lifeng, Zhang, Chunze, Wang, Chenxi, Kong, Dexin, Zhang, Mingzhe, Xu, Tong, Li, Gen, Hu, Ge, Luo, Jiahua, Yee, Sook Wah, Yang, Jia, Stahl, Andreas, Chen, Xin, and Zhang, Youcai
- Subjects
Humans ,beta Catenin ,Animals ,Liver Neoplasms ,Mice ,Cell Line ,Tumor ,Glutathione ,Gene Expression Regulation ,Neoplastic ,TOR Serine-Threonine Kinases ,Wnt Signaling Pathway ,Leucine ,Proto-Oncogene Proteins c-myc ,Amino Acid Transport System y+ ,Carcinoma ,Hepatocellular ,Male ,Large Neutral Amino Acid-Transporter 1 - Abstract
Activated Wnt/β-catenin pathway is a key genetic event in liver cancer development. Solute carrier (SLC) transporters are promising drug targets. Here, we identify SLC13A3 as a drug-targetable effector downstream of β-catenin in liver cancer. SLC13A3 expression is elevated in human liver cancer samples with gain of function (GOF) mutant CTNNB1, the gene encoding β-catenin. Activation of β-catenin up-regulates SLC13A3, leading to intracellular accumulation of endogenous SLC13A3 substrates. SLC13A3 is identified as a low-affinity transporter for glutathione (GSH). Silencing of SLC13A3 downregulates the leucine transporter SLC7A5 via c-MYC signaling, leading to leucine depletion and mTOR inactivation. Furthermore, silencing of SLC13A3 depletes GSH and induces autophagic ferroptosis in β-catenin-activated liver cancer cells. Importantly, both genetic inhibition of SLC13A3 and a small molecule SLC13A3 inhibitor suppress β-catenin-driven hepatocarcinogenesis in mice. Altogether, our study suggests that SLC13A3 could be a promising therapeutic target for treating human liver cancers with GOF CTNNB1 mutations.
- Published
- 2024
18. Dietary supplement use is common in older adult drivers: an analysis from the AAA LongROAD study.
- Author
-
Moran, Ryan, Baird, Sara, DiGuiseppi, Carolyn, Eby, David, Hacker, Sarah, Isom, Chelsea, Jones, Vanya, Lee, Kelly, Li, Guohua, Molnar, Lisa, Patrick, Rudy, Strogatz, David, and Hill, Linda
- Subjects
Dietary supplement ,Older adult ,Polypharmacy ,Supplement ,Humans ,Aged ,Dietary Supplements ,Female ,Male ,Prospective Studies ,Longitudinal Studies ,Automobile Driving ,United States - Abstract
BACKGROUND: Dietary supplement (DS) use is common and increasing among older adults, though much data available on use frequencies are from surveys and performed cross-sectionally. This paper sought to assess the frequency and pattern of dietary supplement use among older adults over time. METHODS: A secondary analysis of data from the AAA LongROAD study, a longitudinal prospective cohort study of older adult drivers, using data from baseline and the first two years of follow up included a total of 2990 drivers aged 65-79 years recruited at five study sites across the US from July 2015 to March 2017. Participants underwent baseline and annual evaluations, which included a brown bag medication review. DS were identified and categorized according to type and key components. Prevalence and pattern of DS use over time and relationship to demographics were measured with frequency and Chi squared analyses. RESULTS: 84% of participants took at least one dietary supplement during the 2-year study period, and 55% of participants continually reported use. DS accounted for approximately 30% of the total pharmacologic-pill burden in all years. Participants who were White non-Hispanic, female, 75-79 years of age at baseline, and on more non-supplement medications took significantly more dietary supplements (P
- Published
- 2024
19. Early biological markers of post-acute sequelae of SARS-CoV-2 infection.
- Author
-
Lu, Scott, Peluso, Michael, Glidden, David, Davidson, Michelle, Lugtu, Kara, Pineda-Ramirez, Jesus, Tassetto, Michel, Garcia-Knight, Miguel, Zhang, Amethyst, Goldberg, Sarah, Chen, Jessica, Fortes-Cobby, Maya, Park, Sara, Martinez, Ana, So, Matthew, Donovan, Aidan, Viswanathan, Badri, Hoh, Rebecca, Donohue, Kevin, McIlwain, David, Gaudiliere, Brice, Anglin, Khamal, Yee, Brandon, Chenna, Ahmed, Winslow, John, Petropoulos, Christos, Deeks, Steven, Briggs-Hagen, Melissa, Andino, Raul, Midgley, Claire, Martin, Jeffrey, Saydah, Sharon, and Kelly, John
- Subjects
Humans ,COVID-19 ,SARS-CoV-2 ,Male ,Female ,Adult ,Viral Load ,Biomarkers ,RNA ,Viral ,Middle Aged ,Post-Acute COVID-19 Syndrome ,Aged ,Cytokines ,Antibodies ,Viral ,Immunoglobulin G - Abstract
To understand the roles of acute-phase viral dynamics and host immune responses in post-acute sequelae of SARS-CoV-2 infection (PASC), we enrolled 136 participants within 5 days of their first positive SARS-CoV-2 real-time PCR test. Participants self-collected up to 21 nasal specimens within the first 28 days post-symptom onset; interviewer-administered questionnaires and blood samples were collected at enrollment, days 9, 14, 21, 28, and month 4 and 8 post-symptom onset. Defining PASC as the presence of any COVID-associated symptom at their 4-month visit, we compared viral markers (quantity and duration of nasal viral RNA load, infectious viral load, and plasma N-antigen level) and host immune markers (IL-6, IL-10, TNF-α, IFN-α, IFN-γ, MCP, IP-10, and Spike IgG) over the acute period. Compared to those who fully recovered, those reporting PASC demonstrated significantly higher maximum levels of SARS-CoV-2 RNA and N-antigen, burden of RNA and infectious viral shedding, and lower Spike-specific IgG levels within 9 days post-illness onset. No significant differences were identified among a panel of host immune markers. Our results suggest early viral dynamics and the associated host immune responses play a role in the pathogenesis of PASC, highlighting the importance of understanding early biological markers in the natural history of PASC.
- Published
- 2024
20. An intronic copy number variation in Syntaxin 17 determines speed of greying and melanoma incidence in Grey horses.
- Author
-
Rubin, Carl-Johan, Hodge, McKaela, Naboulsi, Rakan, Beckman, Madeleine, Bellone, Rebecca, Kallenberg, Angelica, JUsrey, Stephanie, Ohmura, Hajime, Seki, Kazuhiro, Furukawa, Risako, Ohnuma, Aoi, Davis, Brian, Tozaki, Teruaki, Lindgren, Gabriella, and Andersson, Leif
- Subjects
Horses ,Animals ,DNA Copy Number Variations ,Qa-SNARE Proteins ,Melanoma ,Introns ,Hair Color ,Alleles ,Pedigree ,Male ,Female ,Phenotype ,Incidence ,Horse Diseases ,Skin Pigmentation - Abstract
The Greying with age phenotype in horses involves loss of hair pigmentation whereas skin pigmentation is not reduced, and a predisposition to melanoma. The causal mutation was initially reported as a duplication of a 4.6 kb intronic sequence in Syntaxin 17. The speed of greying varies considerably among Grey horses. Here we demonstrate the presence of two different Grey alleles, G2 carrying two tandem copies of the duplicated sequence and G3 carrying three. The latter is by far the most common allele, probably due to strong selection for the striking white phenotype. Our results reveal a remarkable dosage effect where the G3 allele is associated with fast greying and high incidence of melanoma whereas G2 is associated with slow greying and low incidence of melanoma. The copy number expansion transforms a weak enhancer to a strong melanocyte-specific enhancer that underlies hair greying (G2 and G3) and a drastically elevated risk of melanoma (G3 only). Our direct pedigree-based observation of the origin of a G2 allele from a G3 allele by copy number contraction demonstrates the dynamic evolution of this locus and provides the ultimate evidence for causality of the copy number variation of the 4.6 kb intronic sequence.
- Published
- 2024
21. Polymodal K+ channel modulation contributes to dual analgesic and anti-inflammatory actions of traditional botanical medicines.
- Author
-
Manville, Rían, Yoshimura, Ryan, Yeromin, Andriy, Hogenkamp, Derk, van der Horst, Jennifer, Zavala, Angel, Chinedu, Sonia, Arena, Grey, Lasky, Emma, Fisher, Mark, Tracy, Christopher, Othy, Shivashankar, Jepps, Thomas, Cahalan, Michael, and Abbott, Geoffrey
- Subjects
Anti-Inflammatory Agents ,Analgesics ,Animals ,Plant Extracts ,Humans ,Mice ,Coriandrum ,Molecular Docking Simulation ,Plants ,Medicinal ,Potassium Channel Blockers ,Male ,Tannins - Abstract
Pain and inflammation contribute immeasurably to reduced quality of life, yet modern analgesic and anti-inflammatory therapeutics can cause dependence and side effects. Here, we screened 1444 plant extracts, prepared primarily from native species in California and the United States Virgin Islands, against two voltage-gated K+ channels - T-cell expressed Kv1.3 and nociceptive-neuron expressed Kv7.2/7.3. A subset of extracts both inhibits Kv1.3 and activates Kv7.2/7.3 at hyperpolarized potentials, effects predicted to be anti-inflammatory and analgesic, respectively. Among the top dual hits are witch hazel and fireweed; polymodal modulation of multiple K+ channel types by hydrolysable tannins contributes to their dual anti-inflammatory, analgesic actions. In silico docking and mutagenesis data suggest pore-proximal extracellular linker sequence divergence underlies opposite effects of hydrolysable tannins on different Kv1 isoforms. The findings provide molecular insights into the enduring, widespread medicinal use of witch hazel and fireweed and demonstrate a screening strategy for discovering dual anti-inflammatory, analgesic small molecules.
- Published
- 2024
22. Lessons for expanding virtual mentoring in academic medical institutions: a qualitative study among senior mentors.
- Author
-
Riley, Elise, Chur, Elizabeth, Gandhi, Monica, Fuchs, Jonathan, Sauceda, John, Sterling, Lauren, and Johnson, Mallory
- Subjects
Distance mentoring ,Mentoring ,Remote mentoring ,Virtual mentoring ,Humans ,Mentoring ,Female ,Qualitative Research ,Male ,Mentors ,Academic Medical Centers ,Faculty ,Medical ,Adult - Abstract
BACKGROUND: Virtual activities, hybrid work and virtual mentoring have become part of the ongoing milieu of academic medicine. As the shift to remote mentoring continues to evolve, it is now possible to adapt, refine, and improve tools to support thriving mentoring relationships that take place virtually. This study explores strategies for virtual mentoring as a cornerstone for effective training programs among senior mentors participating in an ongoing mentoring program. METHODS: We conducted a qualitative study among prior and current participants of an ongoing Mentoring the Mentors program about key strategies for optimizing virtual mentoring. Data were coded and analyzed following a thematic analysis approach. RESULTS: Respondents were mostly female (62%), white (58%), and associate (39%) or full professors (32%). We found that, with the expansion of hybrid and fully remote work, there are now fewer opportunities for informal but important chance meetings between mentors and mentees; however, virtual mentoring provides opportunities to compensate for reduced interactivity normally experienced in the workplace. The heightened need to plan and be more deliberate in the virtual sphere was woven throughout narratives and was the foundation of most recommendations. Specifically, a central obstacle for respondents was that spontaneous conversations were harder to initiate because virtual conversations are expected to have set agendas. CONCLUSIONS: Developing new ways to maintain meaningful interpersonal relationships in a virtual training environment, including opportunities for serendipitous and informal engagement, is critical to the success of virtual mentoring programs.
- Published
- 2024
23. Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers.
- Author
-
Bhattacharya, Sreyashi, Harris, Hannah, Islam, Ridwan, Bodas, Sanika, Polavaram, Navatha, Mishra, Juhi, Das, Dipanwita, Seshacharyulu, Parthasarathy, Kalluchi, Achyuth, Pal, Anirban, Kohli, Manish, Lele, Subodh, Muders, Michael, Batra, Surinder, Ghosh, Paramita, Datta, Kaustubh, Rowley, M, and Dutta, Samikshan
- Subjects
Humans ,Male ,Docetaxel ,Prostatic Neoplasms ,Drug Resistance ,Neoplasm ,Cell Line ,Tumor ,PAX5 Transcription Factor ,Gene Expression Regulation ,Neoplastic ,Antineoplastic Agents ,Carcinoma ,Neuroendocrine ,Promoter Regions ,Genetic ,Receptors ,Androgen - Abstract
Resistance to the current Androgen Receptor Signaling Inhibitor (ARSI) therapies has led to higher incidences of therapy-induced neuroendocrine-like prostate cancer (t-NEPC). This highly aggressive subtype with predominant small-cell-like characteristics is resistant to taxane chemotherapies and has a dismal overall survival. t-NEPCs are mostly treated with platinum-based drugs with a combination of etoposide or taxane and have less selectivity and high systemic toxicity, which often limit their clinical potential. During t-NEPC transformation, adenocarcinomas lose their luminal features and adopt neuro-basal characteristics. Whether the adaptive neuronal characteristics of t-NEPC are responsible for such taxane resistance remains unknown. Pathway analysis from patient gene-expression databases indicates that t-NEPC upregulates various neuronal pathways associated with enhanced cellular networks. To identify transcription factor(s) (TF) that could be important for promoting the gene expression for neuronal characters in t-NEPC, we performed ATAC-Seq, acetylated-histone ChIP-seq, and RNA-seq in our NE-like cell line models and analyzed the promoters of transcriptionally active and significantly enriched neuroendocrine-like (NE-like) cancer-specific genes. Our results indicate that Pax5 could be an important transcription factor for neuronal gene expression and specific to t-NEPC. Pathway analysis revealed that Pax5 expression is involved in axonal guidance, neurotransmitter regulation, and neuronal adhesion, which are critical for strong cellular communications. Further results suggest that depletion of Pax5 disrupts neurite-mediated cellular communication in NE-like cells and reduces surface growth factor receptor activation, thereby, sensitizing them to docetaxel therapies. Moreover, t-NEPC-specific hydroxymethylation of Pax5 promoter CpG islands favors Pbx1 binding to induce Pax5 expression. Based on our study, we concluded that continuous exposure to ARSI therapies leads to epigenetic modifications and Pax5 activation in t-NEPC, which promotes the expression of genes necessary to adopt taxane-resistant NE-like cancer. Thus, targeting the Pax5 axis can be beneficial for reverting their taxane sensitivity.
- Published
- 2024
24. Improving genetic risk modeling of dementia from real-world data in underrepresented populations.
- Author
-
Fu, Mingzhou, Valiente-Banuet, Leopoldo, Wadhwa, Satpal, Pasaniuc, Bogdan, Vossel, Keith, and Chang, Timothy
- Subjects
Humans ,Dementia ,Genetic Predisposition to Disease ,Female ,Polymorphism ,Single Nucleotide ,Male ,Genome-Wide Association Study ,Aged ,Models ,Genetic ,Multifactorial Inheritance ,Risk Factors ,Risk Assessment ,Middle Aged - Abstract
Genetic risk modeling for dementia offers significant benefits, but studies based on real-world data, particularly for underrepresented populations, are limited. We employ an Elastic Net model for dementia risk prediction using single-nucleotide polymorphisms prioritized by functional genomic data from multiple neurodegenerative disease genome-wide association studies. We compare this model with APOE and polygenic risk score models across genetic ancestry groups (Hispanic Latino American sample: 610 patients with 126 cases; African American sample: 440 patients with 84 cases; East Asian American sample: 673 patients with 75 cases), using electronic health records from UCLA Health for discovery and the All of Us cohort for validation. Our model significantly outperforms other models across multiple ancestries, improving the area-under-precision-recall curve by 31-84% (Wilcoxon signed-rank test p-value
- Published
- 2024
25. Gulf war illness: a tale of two genomes.
- Author
-
Golomb, Beatrice, Kelley, Richard, Han, Jun, Miller, Bruce, and Bui, Leeann
- Subjects
Gulf war illness ,Haplogroup DNA mutations ,Mitochondrial genetics ,Nuclear genetics ,Oxidative stress ,Humans ,Persian Gulf Syndrome ,Middle Aged ,Male ,DNA ,Mitochondrial ,Veterans ,Female ,Haplotypes ,Butyrylcholinesterase ,Adult ,Aged ,Severity of Illness Index - Abstract
INTRODUCTION: Gulf War illness (GWI) is an environmentally-triggered chronic multisymptom illness typified by protean symptoms, in which mitochondrial impairment is evident. It has been likened to accelerated aging. Nuclear genetics of detoxification have been linked to GWI. OBJECTIVE: To see whether mitochondrial (mt) haplogroup U - a heritable profile of mitochondrial DNA that has been tied to aging-related conditions - significantly predicts greater GWI severity; and to assess whether GWI severity is influenced by mitochondrial as well as nuclear genetics. 54 consenting Gulf War veterans gave information on GWI severity, of whom 52 had nuclear DNA assessment; and 45 had both nuclear and mitochondrial DNA assessments. Regression with robust standard errors assessed prediction of GWI severity as a function of nuclear genetics (butyrylcholinesterase variants), mitochondrial genetics (haplogroup U, previously tied to aging-related conditions); or both. RESULTS: BChE adverse variants significantly predicted GWI severity (β(SE) = 23.4(11.4), p = 0.046), as did mt haplogroup U (β(SE) = 36.4(13.6), p = 0.010). In a model including both, BChE was no longer significant, but mt haplogroup U retained significance (β(SE) = 36.7(13.0), p = 0.007). This is the first study to show that mitochondrial genetics are tied to GWI severity in Gulf-deployed veterans. Other data affirm a tie to nuclear genetics, making GWI indeed a tale of two genomes.
- Published
- 2024
26. Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis.
- Author
-
Luijten, Dieuwke, Douillet, Delphine, Luijken, Kim, Tromeur, Cecile, Penaloza, Andrea, Hugli, Olivier, Aujesky, Drahomir, Barco, Stefano, Bledsoe, Joseph, Chang, Kyle, Couturaud, Francis, den Exter, Paul, Font, Carme, Huisman, Menno, Jimenez, David, Kabrhel, Christopher, Kline, Jeffrey, Konstantinides, Stavros, van Mens, Thijs, Otero, Remedios, Peacock, W, Sanchez, Olivier, Stubblefield, William, Valerio, Luca, Vinson, David, Wells, Philip, van Smeden, Maarten, Roy, Pierre-Marie, and Klok, Frederikus
- Subjects
Clinical decision-making ,Early discharge ,Emergency care ,Outpatient care ,Pulmonary embolism ,Humans ,Pulmonary Embolism ,Acute Disease ,Home Care Services ,Hemorrhage ,Male ,Female ,Anticoagulants ,Randomized Controlled Trials as Topic ,Prospective Studies ,Aged ,Natriuretic Peptide ,Brain ,Middle Aged - Abstract
BACKGROUND AND AIMS: Home treatment is considered safe in acute pulmonary embolism (PE) patients selected by a validated triage tool (e.g. simplified PE severity index score or Hestia rule), but there is uncertainty regarding the applicability in underrepresented subgroups. The aim was to evaluate the safety of home treatment by performing an individual patient-level data meta-analysis. METHODS: Ten prospective cohort studies or randomized controlled trials were identified in a systematic search, totalling 2694 PE patients treated at home (discharged within 24 h) and identified by a predefined triage tool. The 14- and 30-day incidences of all-cause mortality and adverse events (combined endpoint of recurrent venous thromboembolism, major bleeding, and/or all-cause mortality) were evaluated. The relative risk (RR) for 14- and 30-day mortalities and adverse events is calculated in subgroups using a random effects model. RESULTS: The 14- and 30-day mortalities were 0.11% [95% confidence interval (CI) 0.0-0.24, I2 = 0) and 0.30% (95% CI 0.09-0.51, I2 = 0). The 14- and 30-day incidences of adverse events were 0.56% (95% CI 0.28-0.84, I2 = 0) and 1.2% (95% CI 0.79-1.6, I2 = 0). Cancer was associated with increased 30-day mortality [RR 4.9; 95% prediction interval (PI) 2.7-9.1; I2 = 0]. Pre-existing cardiopulmonary disease, abnormal troponin, and abnormal (N-terminal pro-)B-type natriuretic peptide [(NT-pro)BNP] at presentation were associated with an increased incidence of 14-day adverse events [RR 3.5 (95% PI 1.5-7.9, I2 = 0), 2.5 (95% PI 1.3-4.9, I2 = 0), and 3.9 (95% PI 1.6-9.8, I2 = 0), respectively], but not mortality. At 30 days, cancer, abnormal troponin, and abnormal (NT-pro)BNP were associated with an increased incidence of adverse events [RR 2.7 (95% PI 1.4-5.2, I2 = 0), 2.9 (95% PI 1.5-5.7, I2 = 0), and 3.3 (95% PI 1.6-7.1, I2 = 0), respectively]. CONCLUSIONS: The incidence of adverse events in home-treated PE patients, selected by a validated triage tool, was very low. Patients with cancer had a three- to five-fold higher incidence of adverse events and death. Patients with increased troponin or (NT-pro)BNP had a three-fold higher risk of adverse events, driven by recurrent venous thromboembolism and bleeding.
- Published
- 2024
27. Impact of diet change on the gut microbiome of common marmosets (Callithrix jacchus).
- Author
-
Tang-Wing, Cassandra, Mohanty, Ipsita, Bryant, MacKenzie, Makowski, Katherine, Melendez, Daira, Dorrestein, Pieter, Knight, Rob, Caraballo-Rodríguez, Andrés, Allaband, Celeste, and Jenné, Keith
- Subjects
marmoset ,metabolome ,metagenomics ,microbiome ,nonhuman microbiome ,nonhuman microbiota ,nutrition ,physiology ,primate ,veterinary microbiology ,Animals ,Callithrix ,Gastrointestinal Microbiome ,Diet ,Male ,Female ,Feces ,Bifidobacterium - Abstract
UNLABELLED: Gastrointestinal diseases are the most frequently reported clinical problems in captive common marmosets (Callithrix jacchus), often affecting the health and welfare of the animal and ultimately their use as a research subject. The microbiome has been shown to be intimately connected to diet and gastrointestinal health. Here, we use shotgun metagenomics and untargeted metabolomics in fecal samples of common marmosets collected before, during, and after a dietary transition from a biscuit to a gel diet. The overall health of marmosets, measured as weight recovery and reproductive outcome, improved after the diet transition. Moreover, each marmoset pair had significant shifts in the microbiome and metabolome after the diet transition. In general, we saw a decrease in Escherichia coli and Prevotella species and an increase in Bifidobacterium species. Untargeted metabolic profiles indicated that polyamine levels, specifically cadaverine and putrescine, were high after diet transition, suggesting either an increase in excretion or a decrease in intestinal reabsorption at the intestinal level. In conclusion, our data suggest that Bifidobacterium species could potentially be useful as probiotic supplements to the laboratory marmoset diet. Future studies with a larger sample size will be beneficial to show that this is consistent with the diet change. IMPORTANCE: Appropriate diet and health of the common marmoset in captivity are essential both for the welfare of the animal and to improve experimental outcomes. Our study shows that a gel diet compared to a biscuit diet improves the health of a marmoset colony, is linked to increases in Bifidobacterium species, and increases the removal of molecules associated with disease. The diet transition had an influence on the molecular changes at both the pair and time point group levels, but only at the pair level for the microbial changes. It appears to be more important which genes and functions present changed rather than specific microbes. Further studies are needed to identify specific components that should be considered when choosing an appropriate diet and additional supplementary foods, as well as to validate the benefits of providing probiotics. Probiotics containing Bifidobacterium species appear to be useful as probiotic supplements to the laboratory marmoset diet, but additional work is needed to validate these findings.
- Published
- 2024
28. Long-Term Safety of Facilitated Subcutaneous Immunoglobulin 10% Treatment in US Clinical Practice in Patients with Primary Immunodeficiency Diseases: Results from a Post-Authorization Safety Study.
- Author
-
Rubinstein, Arye, Mabudian, Mohsen, McNeil, Donald, Patel, Niraj, Wasserman, Richard, Gupta, Sudhir, Carrasco, Paz, Chen, Jie, Garcia, Enrique, Nagy, Andras, and Yel, Leman
- Subjects
Immunogenicity ,Immunoglobulin replacement ,Inborn errors of immunity ,Quality of life ,Tolerability ,Humans ,Male ,Female ,United States ,Adult ,Adolescent ,Prospective Studies ,Hyaluronoglucosaminidase ,Primary Immunodeficiency Diseases ,Middle Aged ,Infusions ,Subcutaneous ,Child ,Young Adult ,Immunoglobulins ,Injections ,Subcutaneous ,Treatment Outcome ,Aged ,Child ,Preschool ,Immunologic Deficiency Syndromes - Abstract
Facilitated subcutaneous immunoglobulin (fSCIG) 10% is an immunoglobulin replacement therapy that utilizes recombinant human hyaluronidase (rHuPH20) to enhance immunoglobulin dispersion and absorption, allowing for longer treatment intervals similar to intravenous immunoglobulin (up to once monthly). fSCIG 10% is indicated in the USA for treating adults and children aged ≥ 2 years with primary immunodeficiency diseases (PIDs). This prospective, non-interventional, open-label, multicenter, post-authorization safety study (NCT02593188) was conducted in the USA from November 2015 to October 2021 to assess the long-term safety of fSCIG 10% in routine clinical practice. Patients with PIDs aged ≥ 16 years who were prescribed and/or had started fSCIG 10% treatment were enrolled. In total, 253 patients were enrolled and included (full analysis set). Participants received fSCIG 10% treatment for a median (interquartile range) of 10.0 (3.5-11.8) months, with the majority of infusions administered every 4 weeks (54.4% [1197/2201 infusions]) and at home (62.6% [1395/2230 infusions]). Overall, 98.5% of infusions were administered without rate reduction, interruption, or discontinuation due to adverse events (AEs). Treatment-related, non-serious AEs were experienced by 52 patients (20.6%, 284 events). Two patients (0.8%) each experienced one treatment-related serious AE (aseptic meningitis and deep vein thrombosis). Development of antibodies against rHuPH20 was uncommon; 14/196 patients (7.1%) tested positive for binding antibodies (titer ≥ 1:160) with no neutralizing antibodies detected. There was no relationship between anti-rHuPH20 antibody positivity and the occurrence of treatment-related serious or non-serious AEs. Long-term, repeated self-administration of fSCIG 10% was well tolerated in US clinical practice by patients with PIDs.
- Published
- 2024
29. Effect of medial stabilizer chest position on pectus bar dislocation.
- Author
-
Melhado, Caroline, Highet, Alexandra, Mukherjee, Neal, Ozgediz, Doruk, Idowu, Olajire, and Kim, Sunghoon
- Subjects
Bar dislocation ,Degrees of freedom ,Pectus excavatum ,Return to full activity ,Stabilizer ,Humans ,Funnel Chest ,Male ,Female ,Adolescent ,Postoperative Complications ,Child ,Retrospective Studies ,Young Adult ,Prostheses and Implants ,Orthopedic Procedures - Abstract
PURPOSE: The current standard method for pectus excavatum (PE) repair is the Nuss procedure. One major postoperative complication is the displacement of the implanted metal bar, which is used to remodel the chest wall. Blocking the possible ways that the bar can be displaced with the use of stabilizers and peri/intracostal sutures has reduced the incidence of bar displacement. Despite the modifications, bar dislocation is often reported. We adopted the medial position stabilizer placement method and imposed no postoperative restrictions. In this study, we analyzed the bar dislocation rate with this modification and concurrent postoperative full activity. METHODS: Nuss procedure modification where stabilizers are placed bilaterally in the medial location was done on patients irrespective of age and Haller index greater than 3.25. A single bar was used for all patients. Cryoanalgesia was performed on every patient. No postoperative restrictions were imposed on the patients. Full immediate activities, including sports, were allowed. RESULTS: 114 patients (103 male, 11 female) were analyzed from 2016 to 2023. The median age was 15 years old. There was zero incidence of bar displacement. The combined incidence of other postoperative complications was 4%: 2 wound infections and 2 hematoma formations, both needing incision and drainage. CONCLUSION: Bilateral medial stabilizer placement resulted in no incidence of bar dislocation. Return to immediate full activities after the Nuss procedure did not appear to increase the incidence of bar displacement if stabilizers were placed medially.
- Published
- 2024
30. Spinal cord injury in high-risk complex adult spinal deformity surgery: review of incidence and outcomes from the Scoli-RISK-1 study.
- Author
-
Jiang, Fan, Joshi, Hetshree, Badhiwala, Jetan, Wilson, Jamie, Lenke, Lawrence, Shaffrey, Christopher, Cheung, Kenneth, Carreon, Leah, Dekutoski, Mark, Schwab, Frank, Boachie-Adjei, Oheneba, Kebaish, Khaled, Ames, Christopher, Berven, Sigurd, Qiu, Yong, Matsuyama, Yukihiro, Dahl, Benny, Mehdian, Hossein, Pellisé, Ferran, Lewis, Stephen, and Fehlings, Michael
- Subjects
Humans ,Spinal Cord Injuries ,Male ,Female ,Middle Aged ,Adult ,Incidence ,Postoperative Complications ,Aged ,Treatment Outcome ,Cohort Studies ,Prospective Studies - Abstract
STUDY DESIGN: Clinical case series. OBJECTIVE: To describe the cause, treatment and outcome of 6 cases of perioperative spinal cord injury (SCI) in high-risk adult deformity surgery. SETTING: Adult spinal deformity patients were enrolled in the multi-center Scoli-RISK-1 cohort study. METHODS: A total of 272 patients who underwent complex adult deformity surgery were enrolled in the prospective, multi-center Scoli-RISK-1 cohort study. Clinical follow up data were available up to a maximum of 2 years after index surgery. Cases of perioperative SCI were identified and an extensive case review was performed. RESULTS: Six individuals with SCI were identified from the Scoli-RISK-1 database (2.2%). Two cases occurred intraoperatively and four cases occurred postoperatively. The first case was an incomplete SCI due to a direct intraoperative insult and was treated postoperatively with Riluzole. The second SCI case was caused by a compression injury due to overcorrection of the deformity. Three cases of incomplete SCI occurred; one case of postoperative hematoma, one case of proximal junctional kyphosis (PJK) and one case of adjacent segment disc herniation. All cases of post-operative incomplete SCI were managed with revision decompression and resulted in excellent clinical recovery. One case of incomplete SCI resulted from infection and PJK. The patients treatment was complicated by a delay in revision and the patient suffered persistent neurological deficits up to six weeks following the onset of SCI. CONCLUSION: Despite the low incidence in high-risk adult deformity surgeries, perioperative SCI can result in devastating consequences. Thus, appropriate postoperative care, follow up and timely management of SCI are essential.
- Published
- 2024
31. Accuracy and validity of determined cause of death and manner of death following forensic autopsy prosection.
- Author
-
Shergill, Armaan, Conner, Peter, Wilson, Machelle, and Omalu, Bennet
- Subjects
Autopsy ,DEATH ,EPIDEMIOLOGY ,FORENSIC PATHOLOGY ,TOXICOLOGY ,Humans ,Autopsy ,Cause of Death ,Male ,Female ,Middle Aged ,Adult ,Aged ,Young Adult ,Aged ,80 and over ,Adolescent ,Reproducibility of Results ,Child ,Infant ,Forensic Pathology ,Child ,Preschool - Abstract
AIMS: The purpose of this study is to evaluate the accuracy and validity of the determination of cause of death (COD) and manner of death (MOD) at the completion of the forensic autopsy prosection. METHODS: We analysed 952 autopsy cases conducted from 2019 to 2020 and compared every patients COD, other significant contributing factors to death (OSC), and MOD after prosection to their COD, OSC and MOD after completion of the final autopsy report. RESULTS: We found that 83% of cases (790 patients) did not have an unexpected change and 17% of cases (162 patients) exhibited a true change in their final diagnosis; the relationship between age and changes in COD and MOD was significant. CONCLUSIONS: Our findings indicate that in the majority of forensic autopsy cases, medical professionals can reasonably complete death certification after the autopsy prosection. In addition to improving the accuracy of COD and MOD, advances in this field will enhance timely decedent affairs management, timely investigations of crimes and timely closure to families who have lost loved ones. We recommend implementing combined interventional education and consultation with expert pathologists, and a well-followed structured method of death classification as the best course of practice.
- Published
- 2024
32. Rhein targets macrophage SIRT2 to promote adipose tissue thermogenesis in obesity in mice.
- Author
-
Zhou, Ruo-Nan, Zhu, Zi-Wei, Xu, Ping-Yuan, Shen, Li-Xuan, Wang, Ziwei, Xue, Ying-Ying, Xiang, Ying-Ying, Cao, Yue, Yu, Xi-Zhong, Zhao, Juan, Jin, Yu, Yan, Jing, Yang, Qin, Fang, Peng-Hua, and Shang, Wen-Bin
- Subjects
Animals ,Male ,Mice ,Adipocytes ,Adipose Tissue ,Anthraquinones ,Inflammasomes ,Macrophages ,Mice ,Inbred C57BL ,NLR Family ,Pyrin Domain-Containing 3 Protein ,Obesity ,Sirtuin 2 ,Thermogenesis - Abstract
Rhein, a component derived from rhubarb, has been proven to possess anti-inflammatory properties. Here, we show that rhein mitigates obesity by promoting adipose tissue thermogenesis in diet-induced obese mice. We construct a macrophage-adipocyte co-culture system and demonstrate that rhein promotes adipocyte thermogenesis through inhibiting NLRP3 inflammasome activation in macrophages. Moreover, clues from acetylome analysis identify SIRT2 as a potential drug target of rhein. We further verify that rhein directly interacts with SIRT2 and inhibits NLRP3 inflammasome activation in a SIRT2-dependent way. Myeloid knockdown of SIRT2 abrogates adipose tissue thermogenesis and metabolic benefits in obese mice induced by rhein. Together, our findings elucidate that rhein inhibits NLRP3 inflammasome activation in macrophages by regulating SIRT2, and thus promotes white adipose tissue thermogenesis during obesity. These findings uncover the molecular mechanism underlying the anti-inflammatory and anti-obesity effects of rhein, and suggest that rhein may become a potential drug for treating obesity.
- Published
- 2024
33. Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120.
- Author
-
Chirenje, Zvavahera, Laher, Fatima, Dintwe, One, Muyoyeta, Monde, deCamp, Allan, He, Zonglin, Grunenberg, Nicole, Laher Omar, Faatima, Seaton, Kelly, Polakowski, Laura, Woodward Davis, Amanda, Maganga, Lucas, Baden, Lindsey, Mayer, Kenneth, Kalams, Spyros, Keefer, Michael, Edupuganti, Srilatha, Rodriguez, Benigno, Frank, Ian, Scott, Hyman, Stranix-Chibanda, Lynda, Gurunathan, Sanjay, Koutsoukos, Marguerite, Van Der Meeren, Olivier, DiazGranados, Carlos, Paez, Carmen, Andersen-Nissen, Erica, Kublin, James, Corey, Lawrence, Ferrari, Guido, Tomaras, Georgia, and McElrath, M
- Subjects
HIV ,adjuvant ,dose ,vaccine ,Humans ,Female ,Adjuvants ,Immunologic ,AIDS Vaccines ,Adult ,Male ,Young Adult ,HIV Infections ,HIV Envelope Protein gp120 ,Adolescent ,Double-Blind Method ,HIV Antibodies ,Squalene ,Polysorbates ,HIV-1 ,Viral Vaccines - Abstract
BACKGROUND: HVTN 120 is a phase 1/2a randomized double-blind placebo-controlled human immunodeficiency virus (HIV) vaccine trial that evaluated the safety and immunogenicity of ALVAC-HIV (vCP2438) and MF59- or AS01B-adjuvanted bivalent subtype C gp120 Env protein at 2 dose levels in healthy HIV-uninfected adults. METHODS: Participants received ALVAC-HIV (vCP2438) alone or placebo at months 0 and 1. At months 3 and 6, participants received either placebo, ALVAC-HIV (vCP2438) with 200 μg of bivalent subtype C gp120 adjuvanted with MF59 or AS01B, or ALVAC-HIV (vCP2438) with 40 μg of bivalent subtype C gp120 adjuvanted with AS01B. Primary outcomes were safety and immune responses. RESULTS: We enrolled 160 participants, 55% women, 18-40 years old (median age 24 years) of whom 150 received vaccine and 10 placebo. Vaccines were generally safe and well tolerated. At months 6.5 and 12, CD4+ T-cell response rates and magnitudes were higher in the AS01B-adjuvanted groups than in the MF59-adjuvanted group. At month 12, HIV-specific Env-gp120 binding antibody response magnitudes in the 40 μg gp120/AS01B group were higher than in either of the 200 μg gp120 groups. CONCLUSIONS: The 40 μg dose gp120/AS01B regimen elicited the highest CD4+ T-cell and binding antibody responses. Clinical Trials Registration . NCT03122223.
- Published
- 2024
34. Exploring the effect of sedentary behavior on increased adiposity in middle-aged adults.
- Author
-
Macías, Nayeli, Monterrubio-Flores, Eric, Salmerón, Jorge, Meneses-León, Joacim, Flores, Yvonne, Jáuregui, Alejandra, Salvo, Deborah, Villa, Umberto, Olvera, Armando, and Gallegos-Carrillo, Katia
- Subjects
Body fat ,Cohort study ,Middle-aged adults ,Sedentary behavior ,Self-report correction ,Humans ,Sedentary Behavior ,Male ,Female ,Middle Aged ,Adult ,Adiposity ,Accelerometry ,Cohort Studies ,Absorptiometry ,Photon ,Self Report ,Surveys and Questionnaires - Abstract
BACKGROUND: Sedentary behavior is linked to excess fat mass; however, this association may be inconclusive due to potential measurement errors in self-reported sedentary behavior. OBJECTIVE: To assess the association between changes in sedentary behavior and fat mass in a Cohort of Health Workers (HWCS) from 2004 to 2010. METHODS: A total of 1,285 adults participating in the Cohort of Health Workers were evaluated in 2004 and 2010. Fat mass (kg) was measured by dual X-ray absorptiometry. A self-administered questionnaire was used to estimate the sedentary behavior. Sedentary behavior was also estimated using accelerometry in a sample of 142 health workers. Accelerometry data were used to correct self-reported sedentary behavior using a generalized linear model, which included values for sleeping time, age, sex, sedentary behavior, glucose, and triglycerides. Concordance between both methods was assessed using a kappa and Bland-Altman analysis. Once sedentary behavior was corrected, the values were used to evaluate the association between changes in sedentary behavior and body fat mass using a fixed effect model in the cohort, adjusting for confounders. RESULTS: Self-reported sedentary behavior was 2.8 ± 1.8 and 2.3 ± 1.6 h/day, and body fat mass was 24.9 ± 8.1 and 26.8 ± 8.5 kg in 2004 and 2010, respectively. After applying the correction model, the self-reported sedentary behavior was 7.6 ± 1.2 and 7.5 ± 1.2 h/day in 2004 and 2010, respectively. For every hour increase in corrected sedentary behavior, there was an observed increase of 0.847 (p > 0.001) kg in body fat mass during the 6.8 years in the Cohort of Health Workers from 2004 to 2010. Conversely, non-corrected self-reported sedentary behavior was associated with a non-significant reduction of 0.097 kg (p = 0.228) for every hour of sedentary behavior. CONCLUSIONS: Increased sedentary behavior was associated with increased body fat mass when corrected self-reported sedentary behavior was used. Implementing public health strategies to reduce sedentary behavior is imperative.
- Published
- 2024
35. Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers
- Author
-
Ellison, Gary L, Helzlsouer, Kathy J, Rosenfield, Sonia M, Kim, Yun, Ashare, Rebecca L, Blaes, Anne H, Cullen, Jennifer, Doran, Neal, Ebbert, Jon O, Egan, Kathleen M, Heffner, Jaimee L, Lee, Richard T, McClure, Erin A, McDaniels-Davidson, Corinne, Meghani, Salimah H, Newcomb, Polly A, Nugent, Shannon, Hernandez-Ortega, Nicholas, Salz, Talya, Vidot, Denise C, Worster, Brooke, and Zylla, Dylan M
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Behavioral and Social Science ,Women's Health ,Cancer ,Clinical Research ,Cannabinoid Research ,Social Determinants of Health ,7.1 Individual care needs ,Humans ,Neoplasms ,Female ,Male ,United States ,Middle Aged ,Prevalence ,Adult ,Medical Marijuana ,National Cancer Institute (U.S.) ,Surveys and Questionnaires ,Cancer Care Facilities ,Aged ,Perception ,Oncology & Carcinogenesis ,Oncology and carcinogenesis - Abstract
BackgroundThe legal climate for cannabis use has dramatically changed with an increasing number of states passing legislation legalizing access for medical and recreational use. Among cancer patients, cannabis is often used to ameliorate adverse effects of cancer treatment. Data are limited on the extent and type of use among cancer patients during treatment and the perceived benefits and harms. This multicenter survey was conducted to assess the use of cannabis among cancer patients residing in states with varied legal access to cannabis.MethodsA total of 12 NCI-Designated Cancer Centers, across states with varied cannabis-access legal status, conducted surveys with a core questionnaire to assess cannabis use among recently diagnosed cancer patients. Data were collected between September 2021 and August 2023 and pooled across 12 cancer centers. Frequencies and 95% confidence intervals for core survey measures were calculated, and weighted estimates are presented for the 10 sites that drew probability samples.ResultsOverall reported cannabis use since cancer diagnosis among survey respondents was 32.9% (weighted), which varied slightly by state legalization status. The most common perceived benefits of use were for pain, sleep, stress and anxiety, and treatment side effects. Reported perceived risks were less common and included inability to drive, difficulty concentrating, lung damage, addiction, and impact on employment. A majority reported feeling comfortable speaking to health-care providers though, overall, only 21.5% reported having done so. Among those who used cannabis since diagnosis, the most common modes were eating in food, smoking, and pills or tinctures, and the most common reasons were for sleep disturbance, followed by pain and stress and anxiety with 60%-68% reporting improved symptoms with use.ConclusionThis geographically diverse survey demonstrates that patients use cannabis regardless of its legal status. Addressing knowledge gaps concerning benefits and harms of cannabis use during cancer treatment is critical to enhance patient-provider communication.
- Published
- 2024
36. An Accurate and Rapidly Calibrating Speech Neuroprosthesis
- Author
-
Card, Nicholas S, Wairagkar, Maitreyee, Iacobacci, Carrina, Hou, Xianda, Singer-Clark, Tyler, Willett, Francis R, Kunz, Erin M, Fan, Chaofei, Vahdati Nia, Maryam, Deo, Darrel R, Srinivasan, Aparna, Choi, Eun Young, Glasser, Matthew F, Hochberg, Leigh R, Henderson, Jaimie M, Shahlaie, Kiarash, Stavisky, Sergey D, and Brandman, David M
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Bioengineering ,Brain Disorders ,Assistive Technology ,Clinical Research ,Neurosciences ,Networking and Information Technology R&D (NITRD) ,ALS ,Rehabilitation ,Neurodegenerative ,Rare Diseases ,Neurological ,Humans ,Middle Aged ,Male ,Brain-Computer Interfaces ,Amyotrophic Lateral Sclerosis ,Dysarthria ,Speech ,Electrodes ,Implanted ,Calibration ,Quadriplegia ,Communication Aids for Disabled ,Microelectrodes ,Medical and Health Sciences ,General & Internal Medicine ,Biomedical and clinical sciences ,Health sciences - Abstract
BackgroundBrain-computer interfaces can enable communication for people with paralysis by transforming cortical activity associated with attempted speech into text on a computer screen. Communication with brain-computer interfaces has been restricted by extensive training requirements and limited accuracy.MethodsA 45-year-old man with amyotrophic lateral sclerosis (ALS) with tetraparesis and severe dysarthria underwent surgical implantation of four microelectrode arrays into his left ventral precentral gyrus 5 years after the onset of the illness; these arrays recorded neural activity from 256 intracortical electrodes. We report the results of decoding his cortical neural activity as he attempted to speak in both prompted and unstructured conversational contexts. Decoded words were displayed on a screen and then vocalized with the use of text-to-speech software designed to sound like his pre-ALS voice.ResultsOn the first day of use (25 days after surgery), the neuroprosthesis achieved 99.6% accuracy with a 50-word vocabulary. Calibration of the neuroprosthesis required 30 minutes of cortical recordings while the participant attempted to speak, followed by subsequent processing. On the second day, after 1.4 additional hours of system training, the neuroprosthesis achieved 90.2% accuracy using a 125,000-word vocabulary. With further training data, the neuroprosthesis sustained 97.5% accuracy over a period of 8.4 months after surgical implantation, and the participant used it to communicate in self-paced conversations at a rate of approximately 32 words per minute for more than 248 cumulative hours.ConclusionsIn a person with ALS and severe dysarthria, an intracortical speech neuroprosthesis reached a level of performance suitable to restore conversational communication after brief training. (Funded by the Office of the Assistant Secretary of Defense for Health Affairs and others; BrainGate2 ClinicalTrials.gov number, NCT00912041.).
- Published
- 2024
37. Real-Time Sensing of Upper Extremity Movement Diversity Using Kurtosis Implemented on a Smartwatch.
- Author
-
Cornella-Barba, Guillem, Okita, Shusuke, Li, Zheng, and Reinkensmeyer, David
- Subjects
accelerometer ,kurtosis ,rehabilitation ,rolling statistics ,tilt sensing ,upper extremity movement diversity ,wearable activity sensing ,Humans ,Upper Extremity ,Movement ,Algorithms ,Wearable Electronic Devices ,Male ,Female ,Adult ,Posture ,Stroke Rehabilitation - Abstract
Wearable activity sensors typically count movement quantity, such as the number of steps taken or the number of upper extremity (UE) counts achieved. However, for some applications, such as neurologic rehabilitation, it may be of interest to quantify the quality of the movement experience (QOME), defined, for example, as how diverse or how complex movement epochs are. We previously found that individuals with UE impairment after stroke exhibited differences in their distributions of forearm postures across the day and that these differences could be quantified with kurtosis-an established statistical measure of the peakedness of distributions. In this paper, we describe further progress toward the goal of providing real-time feedback to try to help people learn to modulate their movement diversity. We first asked the following: to what extent do different movement activities induce different values of kurtosis? We recruited seven unimpaired individuals and evaluated a set of 12 therapeutic activities for their forearm postural diversity using kurtosis. We found that the different activities produced a wide range of kurtosis values, with conventional rehabilitation therapy exercises creating the most spread-out distribution and cup stacking the most peaked. Thus, asking people to attempt different activities can vary movement diversity, as measured with kurtosis. Next, since kurtosis is a computationally expensive calculation, we derived a novel recursive algorithm that enables the real-time calculation of kurtosis. We show that the algorithm reduces computation time by a factor of 200 compared to an optimized kurtosis calculation available in SciPy, across window sizes. Finally, we embedded the kurtosis algorithm on a commercial smartwatch and validated its accuracy using a robotic simulator that wore the smartwatch, emulating movement activities with known kurtosis. This work verifies that different movement tasks produce different values of kurtosis and provides a validated algorithm for the real-time calculation of kurtosis on a smartwatch. These are needed steps toward testing QOME-focused, wearable rehabilitation.
- Published
- 2024
38. Neural Representations of Sensory Uncertainty and Confidence Are Associated with Perceptual Curiosity
- Author
-
Cohanpour, Michael, Aly, Mariam, and Gottlieb, Jacqueline
- Subjects
Biomedical and Clinical Sciences ,Neurosciences ,Behavioral and Social Science ,Basic Behavioral and Social Science ,Clinical Research ,1.1 Normal biological development and functioning ,1.2 Psychological and socioeconomic processes ,Neurological ,Humans ,Male ,Female ,Uncertainty ,Exploratory Behavior ,Adult ,Magnetic Resonance Imaging ,Young Adult ,Brain Mapping ,Photic Stimulation ,Visual Perception ,con fi dence ,curiosity ,information seeking ,noninstrumental ,uncertainty ,visual cortex ,confidence ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Neurology & Neurosurgery - Abstract
Humans are immensely curious and motivated to reduce uncertainty, but little is known about the neural mechanisms that generate curiosity. Curiosity is inversely associated with confidence, suggesting that it is triggered by states of low confidence (subjective uncertainty), but the neural mechanisms of this link, have been little investigated. Inspired by studies of sensory uncertainty, we hypothesized that visual areas provide multivariate representations of uncertainty, which are read out by higher-order structures to generate signals of confidence and, ultimately, curiosity. We scanned participants (17 female, 15 male) using fMRI while they performed a new task in which they rated their confidence in identifying distorted images of animals and objects and their curiosity to see the clear image. We measured the activity evoked by each image in the occipitotemporal cortex (OTC) and devised a new metric of "OTC Certainty" indicating the strength of evidence this activity conveys about the animal versus object categories. We show that, perceptual curiosity peaked at low confidence and OTC Certainty negatively correlated with curiosity, establishing a link between curiosity and a multivariate representation of sensory uncertainty. Moreover, univariate (average) activity in two frontal areas-vmPFC and ACC-correlated positively with confidence and negatively with curiosity, and the vmPFC mediated the relationship between OTC Certainty and curiosity. The results reveal novel mechanisms through which uncertainty about an event generates curiosity about that event.
- Published
- 2024
39. Evaluation of prostate cancer detection using micro-ultrasound versus MRI through co-registration to whole-mount pathology.
- Author
-
Pensa, Jake, Brisbane, Wayne, Kinnaird, Adam, Kuppermann, David, Hughes, Griffith, Ushko, Derrick, Priester, Alan, Gonzalez, Samantha, Reiter, Robert, Chin, Arnold, Sisk, Anthony, Felker, Ely, Marks, Leonard, and Geoghegan, Rory
- Subjects
Co-registration ,Image reconstruction ,MRI ,Micro-ultrasound ,Prostate cancer ,Whole-mount pathology ,Humans ,Prostatic Neoplasms ,Male ,Magnetic Resonance Imaging ,Ultrasonography ,Aged ,Retrospective Studies ,Middle Aged ,Prostate ,Prostatectomy ,Image Processing ,Computer-Assisted - Abstract
Micro-ultrasound has recently been introduced as a low-cost alternative to multi-parametric MRI for imaging prostate cancer. Early clinical studies have demonstrated promising results; however, robust validation via comparison with whole-mount pathology has yet to be achieved. Due to micro-ultrasound probe design and tissue deformation during scanning, it is difficult to accurately correlate micro-ultrasound imaging planes with ground truth whole-mount pathology slides. In this study, we developed a multi-step methodology to co-register micro-ultrasound and MRI to whole-mount pathology. The three-step process had a registration error of 3.90 ± 0.11 mm and consists of: (1) micro-ultrasound image reconstruction, (2) 3D landmark registration of micro-ultrasound to MRI, and (3) 2D capsule registration of MRI to whole-mount pathology. This process was then used in a preliminary reader study to compare the diagnostic accuracy of micro-ultrasound and MRI in 15 patients who underwent radical prostatectomy for prostate cancer. Micro-ultrasound was found to have equivalent performance to retrospective MRI review for index lesion detection (91.7% vs. 80%), while demonstrating an increased detection of tumor extent (52.5% vs. 36.7%) with similar false positive regions-of-interest (38.3% vs. 40.8%). Prospective MRI review had reduced detection of index lesions (73.3%) and tumor extent (18.9%) but improved false positive regions-of-interest (22.7%) relative to micro-ultrasound and retrospective MRI. Further evaluation is needed with a larger sample size.
- Published
- 2024
40. Non-injection drug use among incarcerated people in Iran: Findings from three consecutive national bio-behavioral surveys.
- Author
-
Rafiee, Mahkameh, Karamouzian, Mohammad, Sharifi, Mohammad, Mirzazadeh, Ali, Khezri, Mehrdad, Haghdoost, Ali, Mehmandoost, Soheil, and Sharifi, Hamid
- Subjects
Harm reduction ,Iran ,Prisons ,Substance-related disorders ,Humans ,Iran ,Male ,Adult ,Female ,Prisoners ,Substance-Related Disorders ,Young Adult ,Middle Aged ,Prevalence ,Prisons ,Adolescent ,Risk Factors ,Cross-Sectional Studies - Abstract
BACKGROUND: Prisons often serve as high-risk environments for drug use, and incarcerated people are at a high risk for substance use-related mental and physical harms. This study aimed to determine the prevalence of non-injection drug use inside the prison and its related factors among incarcerated people in Iran. METHODS: We utilized data from three national bio-behavioral surveillance surveys conducted among incarcerated people in Iran in 2009, 2013, and 2017. Eligibility criteria were being ≥ 18 years old, providing informed consent, and being incarcerated for over a week. Overall, 17,228 participants across all surveys were recruited through a multi-stage random sampling approach. Each participant underwent a face-to-face interview and HIV test. The primary objective of the study was to assess self-reported non-injection drug use within the prison environment within the last month. A multivariable logistic regression model was built to determine associated covariates with drug use inside prison and an adjusted odds ratio (aOR) with 95% confidence intervals (CI) were reported. RESULT: The prevalence of non-injection drug use inside the prison was 24.1% (95% CI 23.5, 24.7) with a significant decreasing trend (39.7% in 2009, 17.8% in 2013, 14.0% in 2017; p-value
- Published
- 2024
41. Dimensions of wisdom perception across twelve countries on five continents.
- Author
-
Rudnev, M, Barrett, Harold, Buckwalter, W, Machery, E, Stich, S, Barr, K, Bencherifa, A, Clancy, R, Crone, D, Deguchi, Y, Fabiano, E, Fodeman, A, Guennoun, B, Halamová, J, Hashimoto, T, Homan, J, Kanovský, M, Karasawa, K, Kim, H, Kiper, J, Lee, M, Liu, X, Mitova, V, Nair, R, Pantovic, L, Porter, B, Quintanilla, P, Reijer, J, Romero, P, Singh, P, Tber, S, Wilkenfeld, D, Yi, L, and Grossmann, I
- Subjects
Humans ,Female ,Male ,Adult ,Judgment ,Young Adult ,Emotions ,Knowledge ,Cross-Cultural Comparison ,Cognition ,Middle Aged ,Social Perception ,Adolescent ,Perception - Abstract
Wisdom is the hallmark of social judgment, but how people across cultures recognize wisdom remains unclear-distinct philosophical traditions suggest different views of wisdoms cardinal features. We explore perception of wise minds across 16 socio-economically and culturally diverse convenience samples from 12 countries. Participants assessed wisdom exemplars, non-exemplars, and themselves on 19 socio-cognitive characteristics, subsequently rating targets wisdom, knowledge, and understanding. Analyses reveal two positively related dimensions-Reflective Orientation and Socio-Emotional Awareness. These dimensions are consistent across the studied cultural regions and interact when informing wisdom ratings: wisest targets-as perceived by participants-score high on both dimensions, whereas the least wise are not reflective but moderately socio-emotional. Additionally, individuals view themselves as less reflective but more socio-emotionally aware than most wisdom exemplars. Our findings expand folk psychology and social judgment research beyond the Global North, showing how individuals perceive desirable cognitive and socio-emotional qualities, and contribute to an understanding of mind perception.
- Published
- 2024
42. Associations between gut microbiota and incident fractures in the FINRISK cohort.
- Author
-
Grahnemo, Louise, Kambur, Oleg, Lahti, Leo, Jousilahti, Pekka, Niiranen, Teemu, Knight, Rob, Salomaa, Veikko, Havulinna, Aki, and Ohlsson, Claes
- Subjects
Gastrointestinal Microbiome ,Humans ,Male ,Female ,Fractures ,Bone ,Middle Aged ,Finland ,Aged ,Bacteria ,Metagenome ,Cohort Studies ,Incidence ,Metagenomics ,Proteobacteria ,Risk Factors ,Adult - Abstract
The gut microbiota (GM) can regulate bone mass, but its association with incident fractures is unknown. We used Cox regression models to determine whether the GM composition is associated with incident fractures in the large FINRISK 2002 cohort (n = 7043, 1092 incident fracture cases, median follow-up time 18 years) with information on GM composition and functionality from shotgun metagenome sequencing. Higher alpha diversity was associated with decreased fracture risk (hazard ratio [HR] 0.92 per standard deviation increase in Shannon index, 95% confidence interval 0.87-0.96). For beta diversity, the first principal component was associated with fracture risk (Aitchison distance, HR 0.90, 0.85-0.96). In predefined phyla analyses, we observed that the relative abundance of Proteobacteria was associated with increased fracture risk (HR 1.14, 1.07-1.20), while the relative abundance of Tenericutes was associated with decreased fracture risk (HR 0.90, 0.85-0.96). Explorative sub-analyses within the Proteobacteria phylum showed that higher relative abundance of Gammaproteobacteria was associated with increased fracture risk. Functionality analyses showed that pathways related to amino acid metabolism and lipopolysaccharide biosynthesis associated with fracture risk. The relative abundance of Proteobacteria correlated with pathways for amino acid metabolism, while the relative abundance of Tenericutes correlated with pathways for butyrate synthesis. In conclusion, the overall GM composition was associated with incident fractures. The relative abundance of Proteobacteria, especially Gammaproteobacteria, was associated with increased fracture risk, while the relative abundance of Tenericutes was associated with decreased fracture risk. Functionality analyses demonstrated that pathways known to regulate bone health may underlie these associations.
- Published
- 2024
43. A therapeutic small molecule enhances γ-oscillations and improves cognition/memory in Alzheimers disease model mice.
- Author
-
Wei, Xiaofei, Campagna, Jesus, Jagodzinska, Barbara, Wi, Dongwook, Cohn, Whitaker, Lee, Jessica, Zhu, Chunni, Huang, Christine, Molnár, László, Houser, Carolyn, John, Varghese, and Mody, Istvan
- Subjects
Alzheimer’s disease ,GABA-A receptors ,gamma oscillations ,interneurons ,parvalbumin ,Animals ,Alzheimer Disease ,Mice ,Disease Models ,Animal ,Cognition ,Gamma Rhythm ,Memory ,Receptors ,GABA-A ,Mice ,Transgenic ,Humans ,Male ,Memory ,Short-Term ,Brain ,Alanine ,Azepines - Abstract
Brain rhythms provide the timing for recruitment of brain activity required for linking together neuronal ensembles engaged in specific tasks. The γ-oscillations (30 to 120 Hz) orchestrate neuronal circuits underlying cognitive processes and working memory. These oscillations are reduced in numerous neurological and psychiatric disorders, including early cognitive decline in Alzheimers disease (AD). Here, we report on a potent brain-permeable small molecule, DDL-920 that increases γ-oscillations and improves cognition/memory in a mouse model of AD, thus showing promise as a class of therapeutics for AD. We employed anatomical, in vitro and in vivo electrophysiological, and behavioral methods to examine the effects of our lead therapeutic candidate small molecule. As a novel in central nervous system pharmacotherapy, our lead molecule acts as a potent, efficacious, and selective negative allosteric modulator of the γ-aminobutyric acid type A receptors most likely assembled from α1β2δ subunits. These receptors, identified through anatomical and pharmacological means, underlie the tonic inhibition of parvalbumin (PV) expressing interneurons (PV+INs) critically involved in the generation of γ-oscillations. When orally administered twice daily for 2 wk, DDL-920 restored the cognitive/memory impairments of 3- to 4-mo-old AD model mice as measured by their performance in the Barnes maze. Our approach is unique as it is meant to enhance cognitive performance and working memory in a state-dependent manner by engaging and amplifying the brains endogenous γ-oscillations through enhancing the function of PV+INs.
- Published
- 2024
44. Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry
- Author
-
Schonfeld, Sara J, Valcarcel, Bryan, Meyer, Christa L, Shaw, Bronwen E, Phelan, Rachel, Rizzo, J Douglas, Brunson, Ann, Cooley, Julianne JP, Abrahão, Renata, Wun, Ted, Gadalla, Shahinaz M, Engels, Eric, Albert, Paul S, Yusuf, Rafeek, Spellman, Stephen R, Curtis, Rochelle E, Auletta, Jeffery J, Muffly, Lori, Keegan, Theresa HM, and Morton, Lindsay M
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,HIV/AIDS ,Sexually Transmitted Infections ,Hematology ,Cancer ,Minority Health ,Transplantation ,Clinical Research ,Infectious Diseases ,Humans ,Registries ,Hematopoietic Stem Cell Transplantation ,California ,Incidence ,Female ,Male ,Middle Aged ,Neoplasms ,Adult ,Aged ,Adolescent ,Young Adult ,Child ,Cardiovascular medicine and haematology - Abstract
AbstractCompared with the general population, hematopoietic cell transplantation (HCT) survivors are at elevated risk for developing solid subsequent neoplasms (SNs). The Center for International Blood and Marrow Transplant Research (CIBMTR) is a key resource for quantifying solid SN incidence following HCT, but the completeness of SN ascertainment is uncertain. Within a cohort of 18 450 CIBMTR patients linked to the California Cancer Registry (CCR), we evaluated the completeness of solid SN data reported to the CIBMTR from 1991 to 2018 to understand the implications of using CIBMTR data alone or combined with CCR data to quantify the burden of solid SNs after HCT. We estimated the cumulative incidence of developing a solid SN, accounting for the competing risk of death. Within the cohort, solid SNs were reported among 724 patients; 15.6% of these patients had an SN reported by CIBMTR only, 36.9% by CCR only, and 47.5% by both. The corresponding cumulative incidence of developing a solid SN at 10 years following a first HCT was 4.0% (95% confidence interval [CI], 3.5-4.4) according to CIBMTR data only, 5.3% (95% CI, 4.9-5.9) according to CCR data only, and 6.3% (95% CI, 5.7-6.8) according to both sources combined. The patterns were similar for allogeneic and autologous HCT recipients. Linking detailed HCT information from CIBMTR with comprehensive SN data from cancer registries provides an opportunity to optimize SN ascertainment for informing follow-up care practices and evaluating risk factors in the growing population of HCT survivors.
- Published
- 2024
45. Congenital myasthenic syndrome secondary to pathogenic variants in the SLC5A7 gene: report of two cases.
- Author
-
Muntadas, Javier, Hyland, Martin, Martínez, Maria, Young, Jaime, Chong, Jessica, Bamshad, Michael, and Maselli, Ricardo
- Subjects
SLC5A7 ,Choline transporter 1 ,Congenital myasthenic syndromes ,Episodic apnea ,Presynaptic ,Humans ,Myasthenic Syndromes ,Congenital ,Male ,Mutation ,Symporters ,Child ,Child ,Preschool - Abstract
BACKGROUND: Congenital Myasthenic Syndromes (CMS) are rare genetic diseases, which share as a common denominator muscle fatigability due to failure of neuromuscular transmission. A distinctive clinical feature of presynaptic CMS variants caused by defects of the synthesis of acetylcholine is the association with life-threatening episodes of apnea. One of these variants is caused by mutations in the SLC5A7 gene, which encodes the sodium-dependent HC-3 high-affinity choline transporter 1 (CHT1). To our knowledge there are no published cases of this CMS type in Latin America. CASE PRESENTATION: We present two cases of CHT1-CMS. Both patients were males presenting with repeated episodes of apnea, hypotonia, weakness, ptosis, mild ophthalmoparesis, and bulbar deficit. The first case also presented one isolated seizure, while the second case showed global developmental delay. Both cases, exhibited incomplete improvement with treatment with pyridostigmine. CONCLUSIONS: This report emphasizes the broad incidence of CMS with episodic apnea caused by mutations in the SLC5A7 gene and the frequent association of this condition with serious manifestations of central nervous system involvement.
- Published
- 2024
46. Detection and management of localized prostate cancer in Nigeria: barriers and facilitators according to patients, caregivers and healthcare providers.
- Author
-
Tolani, Musliu, Agbo, Christian, Paciorek, Alan, Umar, Shehu, Ojewola, Rufus, Mohammed, Faruk, Kaninjing, Ernie, Ahmed, Muhammed, and DeBoer, Rebecca
- Subjects
Delivery of health care ,Health services accessibility ,Needs assessment ,Nigeria ,Prostatic neoplasms ,Qualitative research ,Humans ,Male ,Prostatic Neoplasms ,Nigeria ,Focus Groups ,Caregivers ,Middle Aged ,Aged ,Health Personnel ,Health Services Accessibility ,Health Knowledge ,Attitudes ,Practice ,Early Detection of Cancer ,Qualitative Research ,Adult - Abstract
BACKGROUND: Prostate cancer mortality rates are high in Nigeria. While prostate cancer is highly curable with early detection and effective multidisciplinary management, the quality of care is suboptimal in this setting. Sustainable delivery of high-quality care for patients with localized prostate cancer is needed to save more lives. To inform future interventions to improve care, this study aimed to identify barriers and facilitators that influence prostate cancer detection and management in Nigeria. METHODS: Six focus group discussions (FGDs), stratified by stakeholders were conducted with a purposive sample of prostate cancer patients (n = 19), caregivers (n = 15), and healthcare providers (n = 18), in two academic tertiary hospitals in northern and southern Nigeria. A discussion guide organized based on the socio-ecological model was used. FGDs were recorded, transcribed, and analysed using the framework technique. RESULTS: Barriers and facilitators were identified at the individual, interpersonal, and organizational levels. Barriers to detection included limited knowledge and misperceptions among patients, caregivers, and community-based non-specialist healthcare providers, and limitations of centralized opportunistic screening; while facilitators included the potential for religious institutions to encourage positive health-seeking behaviour. Barriers to management included non-uniformity in clinical guideline usage, treatment abandonment amidst concerns about treatment and survival, absence of patient interaction platforms and follow-up support systems, difficulty in navigating service areas, low health insurance coverage and limited financial resource of patients. Facilitators of management included the availability of resource stratified guidelines for prostate cancer management and the availability of patient peers, caregivers, nurses, and medical social workers to provide correct medical information and support patient-centred services. Participants also provided suggestions that could help improve prostate cancer detection and management in Nigeria. CONCLUSION: This study identified multiple determinants affecting the detection and management of localized prostate cancer. These findings will inform the refinement of implementation strategies to improve the quality of prostate cancer care in Nigeria.
- Published
- 2024
47. Genomic profiles and clinical presentation of chordoma.
- Author
-
Koka, Hela, Zhou, Weiyin, McMaster, Mary, Bai, Jiwei, Luo, Wen, Klein, Alyssa, Zhang, Tongwu, Hua, Xing, Li, Xin, Wang, Difei, Xiong, Yujia, Jones, Kristine, Vogt, Aurelie, Hicks, Belynda, Parry, Dilys, Goldstein, Allen, and Yang, Xiaohong
- Subjects
Chordoma ,Chordoma sites ,Clinical outcome ,Genomic landscape ,Treatment ,Humans ,Chordoma ,Male ,Female ,Middle Aged ,Aged ,Adult ,Adolescent ,Young Adult ,Child ,Child ,Preschool ,DNA-Binding Proteins ,Mutation ,Class I Phosphatidylinositol 3-Kinases ,T-Box Domain Proteins ,Transcription Factors ,Nuclear Proteins ,Skull Base Neoplasms ,Spinal Neoplasms ,Canada ,Polymorphism ,Single Nucleotide ,Fetal Proteins ,Histone-Lysine N-Methyltransferase - Abstract
Chordoma is a rare bone cancer with variable clinical outcomes. Here, we recruited 184 sporadic chordoma patients from the US and Canada and collected their clinical and treatment data. The average age at diagnosis was 45.5 years (Range 5-78) and the chordoma site distribution was 49.2% clivus, 26.2% spinal, and 24.0% sacral. Most patients (97.5%) received surgery as the primary treatment, among whom 85.3% also received additional treatment. Except for the most prevalent cancers like prostate, lung, breast, and skin cancer, there was no discernible enrichment for any specific cancer type among patients or their family members. Among a subset of patients (N = 70) with tumor materials, we conducted omics analyses and obtained targeted panel sequencing and SNP array genotyping data for 51 and 49 patients, respectively. The most recurrent somatic driver mutations included PIK3CA (12%), followed by chromatin remodeling genes PBRM1 and SETD2. Amplification of the 6q27 region, containing the chordoma susceptibility gene TBXT, was detected in eight patients (16.3%). Clival patients appeared to be less likely to carry driver gene mutations, chromosome arm level deletion events (e.g., 5p, 5p, and 9p), or 6q27 amplification compared to sacral patients. After adjusting for age, sex, tumor site, and additional treatment, patients with somatic deletions of 14q (OR = 13.73, 95% CI 1.96-96.02, P = 0.008) and 18p (OR = 13.68, 95% CI 1.77-105.89, P = 0.012) were more likely to have persistent chordoma. The study highlights genomic heterogeneity in chordoma, potentially linked to location and clinical progression.
- Published
- 2024
48. Differential stability of task variable representations in retrosplenial cortex.
- Author
-
Franco, Luis and Goard, Michael
- Subjects
Animals ,Neurons ,Mice ,Male ,Mice ,Inbred C57BL ,Choice Behavior ,Cerebral Cortex ,Gyrus Cinguli ,Behavior ,Animal - Abstract
Cortical neurons store information across different timescales, from seconds to years. Although information stability is variable across regions, it can vary within a region as well. Association areas are known to multiplex behaviorally relevant variables, but the stability of their representations is not well understood. Here, we longitudinally recorded the activity of neuronal populations in the mouse retrosplenial cortex (RSC) during the performance of a context-choice association task. We found that the activity of neurons exhibits different levels of stability across days. Using linear classifiers, we quantified the stability of three task-relevant variables. We find that RSC representations of context and trial outcome display higher stability than motor choice, both at the single cell and population levels. Together, our findings show an important characteristic of association areas, where diverse streams of information are stored with varying levels of stability, which may balance representational reliability and flexibility according to behavioral demands.
- Published
- 2024
49. The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta.
- Author
-
Chae, Sehyun, Lee, Hyun-Ju, Lee, Ha-Eun, Kim, Jieun, Jeong, Yoo, Lin, Yuxi, Kim, Hye, Leriche, Geoffray, Ehrlich, Rachel, Lingl, Sascha, Seo, Min-Duk, Lee, Young-Ho, Yang, Jerry, Kim, Jae-Ick, and Hoe, Hyang-Sook
- Subjects
Aβ ,CA140 ,Dopamine D1 receptor ,LTP ,Learning and memory ,Reactive gliosis ,Tau ,Animals ,Alzheimer Disease ,Mice ,Mice ,Transgenic ,Amyloid beta-Peptides ,Neuroinflammatory Diseases ,Signal Transduction ,Receptors ,Dopamine D1 ,Synapses ,Cognition ,Dopamine ,Mice ,Inbred C57BL ,Male ,Humans - Abstract
BACKGROUND: We recently reported that the dopamine (DA) analogue CA140 modulates neuroinflammatory responses in lipopolysaccharide-injected wild-type (WT) mice and in 3-month-old 5xFAD mice, a model of Alzheimers disease (AD). However, the effects of CA140 on Aβ/tau pathology and synaptic/cognitive function and its molecular mechanisms of action are unknown. METHODS: To investigate the effects of CA140 on cognitive and synaptic function and AD pathology, 3-month-old WT mice or 8-month-old (aged) 5xFAD mice were injected with vehicle (10% DMSO) or CA140 (30 mg/kg, i.p.) daily for 10, 14, or 17 days. Behavioral tests, ELISA, electrophysiology, RNA sequencing, real-time PCR, Golgi staining, immunofluorescence staining, and western blotting were conducted. RESULTS: In aged 5xFAD mice, a model of AD pathology, CA140 treatment significantly reduced Aβ/tau fibrillation, Aβ plaque number, tau hyperphosphorylation, and neuroinflammation by inhibiting NLRP3 activation. In addition, CA140 treatment downregulated the expression of cxcl10, a marker of AD-associated reactive astrocytes (RAs), and c1qa, a marker of the interaction of RAs with disease-associated microglia (DAMs) in 5xFAD mice. CA140 treatment also suppressed the mRNA levels of s100β and cxcl10, markers of AD-associated RAs, in primary astrocytes from 5xFAD mice. In primary microglial cells from 5xFAD mice, CA140 treatment increased the mRNA levels of markers of homeostatic microglia (cx3cr1 and p2ry12) and decreased the mRNA levels of a marker of proliferative region-associated microglia (gpnmb) and a marker of lipid-droplet-accumulating microglia (cln3). Importantly, CA140 treatment rescued scopolamine (SCO)-mediated deficits in long-term memory, dendritic spine number, and LTP impairment. In aged 5xFAD mice, these effects of CA140 treatment on cognitive/synaptic function and AD pathology were regulated by dopamine D1 receptor (DRD1)/Elk1 signaling. In primary hippocampal neurons and WT mice, CA140 treatment promoted long-term memory and dendritic spine formation via effects on DRD1/CaMKIIα and/or ERK signaling. CONCLUSIONS: Our results indicate that CA140 improves neuronal/synaptic/cognitive function and ameliorates Aβ/tau pathology and neuroinflammation by modulating DRD1 signaling in primary hippocampal neurons, primary astrocytes/microglia, WT mice, and aged 5xFAD mice.
- Published
- 2024
50. Sustained mucosal colonization and fecal metabolic dysfunction by Bacteroides associates with fecal microbial transplant failure in ulcerative colitis patients.
- Author
-
Zhang, Bing, Magnaye, Kevin, Stryker, Emily, Moltzau-Anderson, Jacqueline, Porsche, Cara, Hertz, Sandra, McCauley, Kathryn, Smith, Byron, Zydek, Martin, Pollard, Katherine, Ma, Averil, El-Nachef, Najwa, and Lynch, Susan
- Subjects
Humans ,Colitis ,Ulcerative ,Fecal Microbiota Transplantation ,Male ,Female ,Feces ,Bacteroides ,Adult ,Intestinal Mucosa ,Middle Aged ,Gastrointestinal Microbiome ,Treatment Failure ,RNA ,Ribosomal ,16S ,Metabolome - Abstract
Fecal microbial transplantation (FMT) offers promise for treating ulcerative colitis (UC), though the mechanisms underlying treatment failure are unknown. This study harnessed longitudinally collected colonic biopsies (n = 38) and fecal samples (n = 179) from 19 adults with mild-to-moderate UC undergoing serial FMT in which antimicrobial pre-treatment and delivery mode (capsules versus enema) were assessed for clinical response (≥ 3 points decrease from the pre-treatment Mayo score). Colonic biopsies underwent dual RNA-Seq; fecal samples underwent parallel 16S rRNA and shotgun metagenomic sequencing as well as untargeted metabolomic analyses. Pre-FMT, the colonic mucosa of non-responsive (NR) patients harbored an increased burden of bacteria, including Bacteroides, that expressed more antimicrobial resistance genes compared to responsive (R) patients. NR patients also exhibited muted mucosal expression of innate immune antimicrobial response genes. Post-FMT, NR and R fecal microbiomes and metabolomes exhibited significant divergence. NR metabolomes had elevated concentrations of immunostimulatory compounds including sphingomyelins, lysophospholipids and taurine. NR fecal microbiomes were enriched for Bacteroides fragilis and Bacteroides salyersiae strains that encoded genes capable of taurine production. These findings suggest that both effective mucosal microbial clearance and reintroduction of bacteria that reshape luminal metabolism associate with FMT success and that persistent mucosal and fecal colonization by antimicrobial-resistant Bacteroides species may contribute to FMT failure.
- Published
- 2024
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.